<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE collection SYSTEM "BioC.dtd">
<collection><source>PMC</source><date>20210825</date><key>pmc.key</key><document><id>8159707</id><infon key="license">NO-CC CODE</infon><passage><infon key="article-id_doi">10.1016/j.ijmedinf.2021.104508</infon><infon key="article-id_pii">S1386-5056(21)00134-9</infon><infon key="article-id_pmc">8159707</infon><infon key="article-id_pmid">34098316</infon><infon key="article-id_publisher-id">104508</infon><infon key="fpage">104508</infon><infon key="kwd">COVID-19 SARS-CoV-2 Personal risk index Vulnerability Mobile crowdsourcing platform Geolocalized survey Point pattern distribution Risk cluster Infection hotspot</infon><infon key="license">Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.</infon><infon key="lpage">104508</infon><infon key="name_0">surname:Ruiz-Correa;given-names:Salvador</infon><infon key="name_1">surname:López-Revilla;given-names:Rubén</infon><infon key="name_10">surname:Mendoza-Lara;given-names:Andrea Rebeca</infon><infon key="name_11">surname:Olivo-Rodríguez;given-names:Montserrat</infon><infon key="name_12">surname:Galván-Ramírez;given-names:Marco Sebastián</infon><infon key="name_13">surname:Morales-Neri;given-names:Ángel Emanuel</infon><infon key="name_14">surname:Martínez-Donjuan;given-names:Víctor Uriel</infon><infon key="name_15">surname:Cervantes-Irurzo;given-names:Massiel Isabella</infon><infon key="name_16">surname:Comas-García;given-names:Andreu</infon><infon key="name_17">surname:Hernández-Maldonado;given-names:Fernando</infon><infon key="name_18">surname:Aguilar-Acosta;given-names:Carlos</infon><infon key="name_2">surname:Díaz-Barriga;given-names:Fernando</infon><infon key="name_3">surname:Marmolejo-Cossío;given-names:Francisco</infon><infon key="name_4">surname:del Carmen Robledo-Valero;given-names:Viridiana</infon><infon key="name_5">surname:Hernández-Huérfano;given-names:Emilio Ernesto</infon><infon key="name_6">surname:Álvarez-Rivera;given-names:Leonardo</infon><infon key="name_7">surname:Rangel-Martínez;given-names:Mónica Liliana</infon><infon key="name_8">surname:Lutzow-Steiner;given-names:Miguel Ángel</infon><infon key="name_9">surname:Ortiz-Vázquez;given-names:Luis Alfredo</infon><infon key="section_type">TITLE</infon><infon key="title">Keywords</infon><infon key="type">front</infon><infon key="volume">153</infon><infon key="year">2021</infon><offset>0</offset><text>Health Sentinel: A mobile crowdsourcing platform for self-reported surveys provides early detection of COVID-19 clusters in San Luis Potosí, Mexico</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>149</offset><text>Background</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>160</offset><text>The Health Sentinel (Centinela de la Salud, CDS), a mobile crowdsourcing platform that includes the CDS app, was deployed to assess its utility as a tool for COVID-19 surveillance in San Luis Potosí, Mexico.</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>369</offset><text>Methods</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>377</offset><text>The CDS app allowed anonymized individual surveys of demographic features and COVID-19 risk of transmission and exacerbation factors from users of the San Luis Potosí Metropolitan Area (SLPMA). The platform’s data processing pipeline computed and geolocalized the risk index of each user and enabled the analysis of the variables and their association. Point process analysis identified geographic clustering patterns of users at risk and these were compared with the patterns of COVID-19 cases confirmed by the State Health Services.</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>915</offset><text>Results</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>923</offset><text>A total of 1554 COVID-19 surveys were administered through the CDS app. Among the respondents, 50.4 % were men and 49.6 % women, with an average age of 33.5 years. Overall risk index frequencies were, in descending order: no-risk 77.8 %, low risk 10.6 %, respiratory symptoms 6.7 %, medium risk 1.4 %, high risk 2.0 %, very high risk 1.5 %. Comorbidity was the most frequent vulnerability category (32.4 %), followed by the inability to keep home lockdown (19.2 %). Statistically significant risk clusters identified at a spatial scale between 5 and 730 m coincided with those in neighborhoods containing substantial numbers of confirmed COVID-19 cases.</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>1577</offset><text>Conclusions</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>1589</offset><text>The CDS platform enables the analysis of the sociodemographic features and spatial distribution of individual risk indexes of COVID-19 transmission and exacerbation. It is a useful epidemiological surveillance and early detection tool because it identifies statistically significant and consistent risk clusters in neighborhoods with a substantial number of confirmed COVID-19 cases.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>1973</offset><text>Introduction</text></passage><passage><infon key="file">tbl0005.xml</infon><infon key="id">tbl0005</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>1986</offset><text>Main COVID-19 features in Mexico.</text></passage><passage><infon key="file">tbl0005.xml</infon><infon key="id">tbl0005</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;&lt;list list-type=&quot;simple&quot; id=&quot;lis0005&quot;&gt;&lt;list-item id=&quot;lsti0005&quot;&gt;&lt;label&gt;1&lt;/label&gt;&lt;p id=&quot;par0005&quot;&gt;Around 80 % of patients infected by SARS-CoV-2 recover without needing hospital admission.&lt;/p&gt;&lt;/list-item&gt;&lt;list-item id=&quot;lsti0010&quot;&gt;&lt;label&gt;2&lt;/label&gt;&lt;p id=&quot;par0010&quot;&gt;Around one out of five people who get COVID-19 become seriously ill and develop difficulty breathing.&lt;/p&gt;&lt;/list-item&gt;&lt;list-item id=&quot;lsti0015&quot;&gt;&lt;label&gt;3&lt;/label&gt;&lt;p id=&quot;par0015&quot;&gt;Obesity is the strongest predictor for COVID-19, followed by diabetes and hypertension in both sexes, and chronic renal failure in women only.&lt;/p&gt;&lt;/list-item&gt;&lt;list-item id=&quot;lsti0020&quot;&gt;&lt;label&gt;4&lt;/label&gt;&lt;p id=&quot;par0020&quot;&gt;Active smoking is associated with an increased risk of COVID-19.&lt;/p&gt;&lt;/list-item&gt;&lt;list-item id=&quot;lsti0025&quot;&gt;&lt;label&gt;5&lt;/label&gt;&lt;p id=&quot;par0025&quot;&gt;Men are more likely to be hospitalized and to die than women.&lt;/p&gt;&lt;/list-item&gt;&lt;list-item id=&quot;lsti0030&quot;&gt;&lt;label&gt;6&lt;/label&gt;&lt;p id=&quot;par0030&quot;&gt;Individuals more than 50 years old are more likely to be hospitalized and die.&lt;/p&gt;&lt;/list-item&gt;&lt;list-item id=&quot;lsti0035&quot;&gt;&lt;label&gt;7&lt;/label&gt;&lt;p id=&quot;par0035&quot;&gt;Individuals with hypertension, obesity, and diabetes are more likely to be hospitalized and die than those without these morbidities.&lt;/p&gt;&lt;/list-item&gt;&lt;list-item id=&quot;lsti0040&quot;&gt;&lt;label&gt;8&lt;/label&gt;&lt;p id=&quot;par0040&quot;&gt;Individuals infected by SARS-CoV-2 have a higher chance of dying if they are simultaneously affected by two or more chronic conditions.&lt;/p&gt;&lt;/list-item&gt;&lt;list-item id=&quot;lsti0045&quot;&gt;&lt;label&gt;9&lt;/label&gt;&lt;p id=&quot;par0045&quot;&gt;There is a high risk of fatal complications from COVID-19 due to the high prevalence of chronic non-degenerative diseases in Mexicans.&lt;/p&gt;&lt;/list-item&gt;&lt;/list&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>2020</offset><text>Table 1	 	</text></passage><passage><infon key="file">tbl0005.xml</infon><infon key="id">tbl0005</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;&lt;list list-type=&quot;simple&quot; id=&quot;lis0005&quot;&gt;&lt;list-item id=&quot;lsti0005&quot;&gt;&lt;label&gt;1&lt;/label&gt;&lt;p id=&quot;par0005&quot;&gt;Around 80 % of patients infected by SARS-CoV-2 recover without needing hospital admission.&lt;/p&gt;&lt;/list-item&gt;&lt;list-item id=&quot;lsti0010&quot;&gt;&lt;label&gt;2&lt;/label&gt;&lt;p id=&quot;par0010&quot;&gt;Around one out of five people who get COVID-19 become seriously ill and develop difficulty breathing.&lt;/p&gt;&lt;/list-item&gt;&lt;list-item id=&quot;lsti0015&quot;&gt;&lt;label&gt;3&lt;/label&gt;&lt;p id=&quot;par0015&quot;&gt;Obesity is the strongest predictor for COVID-19, followed by diabetes and hypertension in both sexes, and chronic renal failure in women only.&lt;/p&gt;&lt;/list-item&gt;&lt;list-item id=&quot;lsti0020&quot;&gt;&lt;label&gt;4&lt;/label&gt;&lt;p id=&quot;par0020&quot;&gt;Active smoking is associated with an increased risk of COVID-19.&lt;/p&gt;&lt;/list-item&gt;&lt;list-item id=&quot;lsti0025&quot;&gt;&lt;label&gt;5&lt;/label&gt;&lt;p id=&quot;par0025&quot;&gt;Men are more likely to be hospitalized and to die than women.&lt;/p&gt;&lt;/list-item&gt;&lt;list-item id=&quot;lsti0030&quot;&gt;&lt;label&gt;6&lt;/label&gt;&lt;p id=&quot;par0030&quot;&gt;Individuals more than 50 years old are more likely to be hospitalized and die.&lt;/p&gt;&lt;/list-item&gt;&lt;list-item id=&quot;lsti0035&quot;&gt;&lt;label&gt;7&lt;/label&gt;&lt;p id=&quot;par0035&quot;&gt;Individuals with hypertension, obesity, and diabetes are more likely to be hospitalized and die than those without these morbidities.&lt;/p&gt;&lt;/list-item&gt;&lt;list-item id=&quot;lsti0040&quot;&gt;&lt;label&gt;8&lt;/label&gt;&lt;p id=&quot;par0040&quot;&gt;Individuals infected by SARS-CoV-2 have a higher chance of dying if they are simultaneously affected by two or more chronic conditions.&lt;/p&gt;&lt;/list-item&gt;&lt;list-item id=&quot;lsti0045&quot;&gt;&lt;label&gt;9&lt;/label&gt;&lt;p id=&quot;par0045&quot;&gt;There is a high risk of fatal complications from COVID-19 due to the high prevalence of chronic non-degenerative diseases in Mexicans.&lt;/p&gt;&lt;/list-item&gt;&lt;/list&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>2031</offset><text>Around 80 % of patients infected by SARS-CoV-2 recover without needing hospital admission.Around one out of five people who get COVID-19 become seriously ill and develop difficulty breathing.Obesity is the strongest predictor for COVID-19, followed by diabetes and hypertension in both sexes, and chronic renal failure in women only.Active smoking is associated with an increased risk of COVID-19.Men are more likely to be hospitalized and to die than women.Individuals more than 50 years old are more likely to be hospitalized and die.Individuals with hypertension, obesity, and diabetes are more likely to be hospitalized and die than those without these morbidities.Individuals infected by SARS-CoV-2 have a higher chance of dying if they are simultaneously affected by two or more chronic conditions.There is a high risk of fatal complications from COVID-19 due to the high prevalence of chronic non-degenerative diseases in Mexicans.	 	</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>2973</offset><text>The coronavirus disease 2019 (COVID-19) epidemic in Mexico is part of the pandemic caused by the Severe Acute Respiratory Syndrome Coronavirus Virus 2, SARS-CoV-2. Mexican health authorities confirmed the first COVID-19 case on February 27, 2020 and declared a health emergency on April 9, 2020. Mitigation measures implemented in early March 2020 to avoid healthcare saturation, included voluntary home confinement, maintaining a safe distance between people, suspension of non-critical school and work activities, and frequent hand hygiene. At the time of writing (January 27, 2021), there had been 1,788,905 confirmed COVID-19 cases, 152,016 deaths, and a case fatality ratio (CFR) of 8.5 % in Mexico, the country with the largest CFR. COVID-19 features in Mexico are summarized in Table 1 . The disease quickly spread across Mexican cities and on March 13 the first case was confirmed in the San Luis Potosí Metropolitan Area (SLPMA); at the time of writing, the state of San Luis Potosí had 48,486 confirmed cases, and 3632 deaths.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>4012</offset><text>COVID-19 spreads in clusters, as individuals pass the virus to their contacts, resulting in clusters of geographically localized infections. Cluster mapping has been useful to explore transmission characterized by spatial features distinctive of early infection scattering, community spread, and full-scale outbreak. Epidemiological surveillance of COVID-19 cases in Mexico is carried out through sentinel surveillance for early detection of suspected cases through their most frequent signs and symptoms and epidemiological antecedents. Only 0.4 qRT-PCR COVID-19 tests per 1000 inhabitants have been administered since only symptomatic subjects are eligible for testing.</text></passage><passage><infon key="file">tbl0010.xml</infon><infon key="id">tbl0010</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>4684</offset><text>Research questions addressed in this study.</text></passage><passage><infon key="file">tbl0010.xml</infon><infon key="id">tbl0010</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;RQ1: What are the sociodemographic features of the app users?&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;RQ2: How are the risk indexes of the app users geographically distributed?&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;RQ3: Does the point-pattern distribution of risk cases and confirmed COVID-19 cases show statistically significant and consistent clustering features?&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;RQ4: At what spatial scale are the clustering features of risk cases statistically significant; do they change with time and correlate with the clustering features of COVID-19 confirmed cases?&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>4728</offset><text>Table 2	 	</text></passage><passage><infon key="file">tbl0010.xml</infon><infon key="id">tbl0010</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;RQ1: What are the sociodemographic features of the app users?&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;RQ2: How are the risk indexes of the app users geographically distributed?&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;RQ3: Does the point-pattern distribution of risk cases and confirmed COVID-19 cases show statistically significant and consistent clustering features?&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;RQ4: At what spatial scale are the clustering features of risk cases statistically significant; do they change with time and correlate with the clustering features of COVID-19 confirmed cases?&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>4739</offset><text>RQ1: What are the sociodemographic features of the app users?	 	RQ2: How are the risk indexes of the app users geographically distributed?	 	RQ3: Does the point-pattern distribution of risk cases and confirmed COVID-19 cases show statistically significant and consistent clustering features?	 	RQ4: At what spatial scale are the clustering features of risk cases statistically significant; do they change with time and correlate with the clustering features of COVID-19 confirmed cases?	 	</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>5229</offset><text>COVID-19 apps are informational, self-assessment/medical-reporting, contact tracing, multipurpose, and others; multipurpose apps combine the functionality of at least two of the first three categories. The limited resources to conduct diagnostic tests for early detection of SARS-CoV-2 in San Luis Potosí prompted us to develop the Health Sentinel (CDS), a mobile crowdsourcing platform with a multipurpose app (Table S 1) for collecting real-time surveys of self-reported demographic data, signs and symptoms, and vulnerabilities related to COVID-19. The CDS app also serves as a public surveillance tool, to educate users about their risk, and as a community triage to support the Epidemiological Intelligence task force of the UASLP School of Medicine to address the COVID-19 pandemic. CDS data collected from April 1 to July 31, 2020, presented here address the research questions listed in Table 2 .</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_1</infon><offset>6135</offset><text>Methods</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>6143</offset><text>Study design</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>6156</offset><text>This study stemmed from the local VIRUS Program, inspired by the United Nations Human Security methodology, focused on collective actions to address community threats and comorbidities associated with COVID-19. It allowed our research team to evaluate the potential contribution of the CDS app for epidemiological surveillance of COVID-19 in the SLPMA, through a descriptive analysis of the users (demographics, risk categories, geographic location, and clusters), and by statistically comparing their spatial and temporal distribution with confirmed COVID-19 cases as a way of validating the CDS app (Table 2).</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>6768</offset><text>Setting and participants</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>6793</offset><text>The SLPMA includes the San Luis Potosi City and Soledad de Graciano Sánchez municipalities, subdivided into primary geostatistical areas (AGEBs). Data collected in the SLPMA consists of two distinct data sets: one originating from survey responses of volunteer app users, and another one of confirmed COVID-19 cases provided by the local health department. Out of the 9971 anonymized COVID-19 cases confirmed through qRT-PCR tests between March 12 and August 3 in the SLPMA, only 9453 (94.8 %) with known postal addresses were included. Privacy laws did not allow app users to indicate if they had been tested and included in the COVID-19 confirmed cases database.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>7459</offset><text>The Mexican Health Ministry established that COVID-19 testing was required for people with suspected COVID-19 symptoms. The overall spectrum of symptom severity is included in the confirmed cases database.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>7665</offset><text>Federal regulations require subjects manifesting COVID-19 symptoms to provide consent for the use of their data. SSSLP records were stored in the National Supercomputing Center data center at IPICYT, a tier 3 facility designed to assure data integrity and privacy according to Mexican law. Only authorized personnel had access to the SSSLP data.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>8011</offset><text>The CDS requires 11.76 MB of data space and uses state-of-the-art mobile crowdsourcing to collect self-assessment survey data; it was deployed on April 1, 2020, in the SLPMA, and became available through Google Play Store on May 1. CDS app users do not require a personal account and their data are sent to the cloud through an open Wi-Fi connection to prevent the use of their data; users can participate multiple times. The local health department registered the CDS app after checking its compliance with data privacy, security, and ethical requirements. To activate the app, users had to read and agree with the terms of use and consent form. CDS architecture is described in Appendix A. The CDS app was available for Android OS only; 68.3 % of Mexico’s population has access to a smartphone, with 82.5 % Android OS users, and 17.1 % iOS users.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>8862</offset><text>Personal COVID-19 risk index assessment</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>8902</offset><text>A group of medical and public health experts from UASLP School of Medicine, SSSLP, and IPICYT developed the algorithm to compute the individual risk assessment. Risk calculation combines information about the risk of infection and risk of disease severity into one category. This category is most useful at the individual level to help users decide on an informed course of action by following official recommendations from local health authorities, based on the COVID-19 operational definition of the World Health Organization. This category is also helpful to understand the risk of infection across the SLPMA area, but its use to investigate the risk of severity is limited.</text></passage><passage><infon key="file">tbl0015.xml</infon><infon key="id">tbl0015</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>9580</offset><text>Survey questions of the three risk categories.</text></passage><passage><infon key="file">tbl0015.xml</infon><infon key="id">tbl0015</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot;&gt;&lt;thead&gt;&lt;tr&gt;&lt;th align=&quot;left&quot;&gt;Risk category&lt;/th&gt;&lt;th align=&quot;left&quot;&gt;Questions&lt;/th&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;3&quot;&gt;Contact factors&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;&lt;list list-type=&quot;simple&quot; id=&quot;lis0010&quot;&gt;&lt;list-item id=&quot;lsti0050&quot;&gt;&lt;label&gt;1&lt;/label&gt;&lt;p id=&quot;par0050&quot;&gt;During the last 14 days have you traveled, had close contact with people who have traveled outside the country or who have come from abroad?&lt;/p&gt;&lt;/list-item&gt;&lt;/list&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;&lt;list list-type=&quot;simple&quot; id=&quot;lis0015&quot;&gt;&lt;list-item id=&quot;lsti0055&quot;&gt;&lt;label&gt;2&lt;/label&gt;&lt;p id=&quot;par0055&quot;&gt;Have you had close contact with someone with signs of COVID-19 (cough, fever, shortness of breath), even though they have not had the confirmation test?&lt;/p&gt;&lt;/list-item&gt;&lt;/list&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;&lt;list list-type=&quot;simple&quot; id=&quot;lis0020&quot;&gt;&lt;list-item id=&quot;lsti0060&quot;&gt;&lt;label&gt;3&lt;/label&gt;&lt;p id=&quot;par0060&quot;&gt;Have you had close contact with someone who tested positive for COVID-19 or was with the disease by a doctor?&lt;/p&gt;&lt;/list-item&gt;&lt;/list&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;3&quot;&gt;Signs and symptoms&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;&lt;list list-type=&quot;simple&quot; id=&quot;lis0025&quot;&gt;&lt;list-item id=&quot;lsti0065&quot;&gt;&lt;label&gt;4&lt;/label&gt;&lt;p id=&quot;par0065&quot;&gt;During the last 7 days, have you had these two symptoms, cough and fever higher than 37.5 °C?&lt;/p&gt;&lt;/list-item&gt;&lt;/list&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;&lt;list list-type=&quot;simple&quot; id=&quot;lis0030&quot;&gt;&lt;list-item id=&quot;lsti0070&quot;&gt;&lt;label&gt;5&lt;/label&gt;&lt;p id=&quot;par0070&quot;&gt;During the last 7 days, have you had any of these symptoms: headache, muscle aches, extreme tiredness, sore throat, joint pain, diarrhea?&lt;/p&gt;&lt;/list-item&gt;&lt;/list&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;&lt;list list-type=&quot;simple&quot; id=&quot;lis0035&quot;&gt;&lt;list-item id=&quot;lsti0075&quot;&gt;&lt;label&gt;6&lt;/label&gt;&lt;p id=&quot;par0075&quot;&gt;During the last 7 days, have you had any other respiratory additional symptoms such as shortness of breath, and chest pain?&lt;/p&gt;&lt;/list-item&gt;&lt;/list&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;2&quot;&gt;High risk and comorbidity factors&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;&lt;list list-type=&quot;simple&quot; id=&quot;lis0040&quot;&gt;&lt;list-item id=&quot;lsti0080&quot;&gt;&lt;label&gt;7&lt;/label&gt;&lt;p id=&quot;par0080&quot;&gt;Do you have one or more of these conditions: pregnancy, 65 years or older, work in a place where you serve people (gas station, food store, banks, informal work)?&lt;/p&gt;&lt;/list-item&gt;&lt;/list&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;&lt;list list-type=&quot;simple&quot; id=&quot;lis0045&quot;&gt;&lt;list-item id=&quot;lsti0085&quot;&gt;&lt;label&gt;8&lt;/label&gt;&lt;p id=&quot;par0085&quot;&gt;Do you have one or more of these diseases: diabetes, hypertension, heart problems, liver problems, asthma, COPD, HIV/AIDS, cancer, chronic kidney failure, obesity, smoking?&lt;/p&gt;&lt;/list-item&gt;&lt;/list&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>9627</offset><text>Table 3	 	</text></passage><passage><infon key="file">tbl0015.xml</infon><infon key="id">tbl0015</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot;&gt;&lt;thead&gt;&lt;tr&gt;&lt;th align=&quot;left&quot;&gt;Risk category&lt;/th&gt;&lt;th align=&quot;left&quot;&gt;Questions&lt;/th&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;3&quot;&gt;Contact factors&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;&lt;list list-type=&quot;simple&quot; id=&quot;lis0010&quot;&gt;&lt;list-item id=&quot;lsti0050&quot;&gt;&lt;label&gt;1&lt;/label&gt;&lt;p id=&quot;par0050&quot;&gt;During the last 14 days have you traveled, had close contact with people who have traveled outside the country or who have come from abroad?&lt;/p&gt;&lt;/list-item&gt;&lt;/list&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;&lt;list list-type=&quot;simple&quot; id=&quot;lis0015&quot;&gt;&lt;list-item id=&quot;lsti0055&quot;&gt;&lt;label&gt;2&lt;/label&gt;&lt;p id=&quot;par0055&quot;&gt;Have you had close contact with someone with signs of COVID-19 (cough, fever, shortness of breath), even though they have not had the confirmation test?&lt;/p&gt;&lt;/list-item&gt;&lt;/list&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;&lt;list list-type=&quot;simple&quot; id=&quot;lis0020&quot;&gt;&lt;list-item id=&quot;lsti0060&quot;&gt;&lt;label&gt;3&lt;/label&gt;&lt;p id=&quot;par0060&quot;&gt;Have you had close contact with someone who tested positive for COVID-19 or was with the disease by a doctor?&lt;/p&gt;&lt;/list-item&gt;&lt;/list&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;3&quot;&gt;Signs and symptoms&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;&lt;list list-type=&quot;simple&quot; id=&quot;lis0025&quot;&gt;&lt;list-item id=&quot;lsti0065&quot;&gt;&lt;label&gt;4&lt;/label&gt;&lt;p id=&quot;par0065&quot;&gt;During the last 7 days, have you had these two symptoms, cough and fever higher than 37.5 °C?&lt;/p&gt;&lt;/list-item&gt;&lt;/list&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;&lt;list list-type=&quot;simple&quot; id=&quot;lis0030&quot;&gt;&lt;list-item id=&quot;lsti0070&quot;&gt;&lt;label&gt;5&lt;/label&gt;&lt;p id=&quot;par0070&quot;&gt;During the last 7 days, have you had any of these symptoms: headache, muscle aches, extreme tiredness, sore throat, joint pain, diarrhea?&lt;/p&gt;&lt;/list-item&gt;&lt;/list&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;&lt;list list-type=&quot;simple&quot; id=&quot;lis0035&quot;&gt;&lt;list-item id=&quot;lsti0075&quot;&gt;&lt;label&gt;6&lt;/label&gt;&lt;p id=&quot;par0075&quot;&gt;During the last 7 days, have you had any other respiratory additional symptoms such as shortness of breath, and chest pain?&lt;/p&gt;&lt;/list-item&gt;&lt;/list&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;2&quot;&gt;High risk and comorbidity factors&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;&lt;list list-type=&quot;simple&quot; id=&quot;lis0040&quot;&gt;&lt;list-item id=&quot;lsti0080&quot;&gt;&lt;label&gt;7&lt;/label&gt;&lt;p id=&quot;par0080&quot;&gt;Do you have one or more of these conditions: pregnancy, 65 years or older, work in a place where you serve people (gas station, food store, banks, informal work)?&lt;/p&gt;&lt;/list-item&gt;&lt;/list&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;&lt;list list-type=&quot;simple&quot; id=&quot;lis0045&quot;&gt;&lt;list-item id=&quot;lsti0085&quot;&gt;&lt;label&gt;8&lt;/label&gt;&lt;p id=&quot;par0085&quot;&gt;Do you have one or more of these diseases: diabetes, hypertension, heart problems, liver problems, asthma, COPD, HIV/AIDS, cancer, chronic kidney failure, obesity, smoking?&lt;/p&gt;&lt;/list-item&gt;&lt;/list&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>9638</offset><text>Risk category	Questions	 	Contact factors	During the last 14 days have you traveled, had close contact with people who have traveled outside the country or who have come from abroad?	 	Have you had close contact with someone with signs of COVID-19 (cough, fever, shortness of breath), even though they have not had the confirmation test?	 	Have you had close contact with someone who tested positive for COVID-19 or was with the disease by a doctor?	 	Signs and symptoms	During the last 7 days, have you had these two symptoms, cough and fever higher than 37.5 °C?	 	During the last 7 days, have you had any of these symptoms: headache, muscle aches, extreme tiredness, sore throat, joint pain, diarrhea?	 	During the last 7 days, have you had any other respiratory additional symptoms such as shortness of breath, and chest pain?	 	High risk and comorbidity factors	Do you have one or more of these conditions: pregnancy, 65 years or older, work in a place where you serve people (gas station, food store, banks, informal work)?	 	Do you have one or more of these diseases: diabetes, hypertension, heart problems, liver problems, asthma, COPD, HIV/AIDS, cancer, chronic kidney failure, obesity, smoking?	 	</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>10847</offset><text>The personal profile includes the user’s gender, age, and occupation. Risk index calculation depends on three categories of variables: contact, signs-and-symptoms, and comorbidity. The CDS app enables the administration of the eight questions on risk items (Table 3 ), conforming to the COVID-19 guidelines of the World Health Organization and the Mexican System for Epidemiological Surveillance.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>11246</offset><text>Contact considers whether the user recently traveled to a country with a COVID-19 epidemic, had close contact with someone recently returned from abroad, or has suspected or confirmed infection. Signs and symptoms include cough and fever above 37.5 °C, six general symptoms, and two respiratory symptoms. Comorbidity includes risk factors that can exacerbate the disease, and whether the user belongs to one or more risk groups or has one or more concomitant illnesses that can worsen COVID-19. Risk groups are pregnant women and people aged 65 years or more. Concomitant diseases include diabetes, hypertension, heart problems, liver disease, asthma, chronic pulmonary obstructive disease (COPD), HIV/AIDS, cancer, chronic kidney failure, obesity, and smoking which increase the risk of fatal outcomes associated with COVID-19. Two questions address social vulnerabilities: 1) Can you stay home regardless of developing COVID-19 symptoms? and 2) Do you have someone (relative, friend, neighbor) who can help you in case you get ill?; these questions are motivated by the fact that a significant proportion of Mexicans have informal employment and cannot stay at home.</text></passage><passage><infon key="file">tbl0020.xml</infon><infon key="id">tbl0020</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>12416</offset><text>Calculation of the users’ risk index. (For interpretation of the references to color in this table, the reader is referred to the web version of this article).</text></passage><passage><infon key="file">tbl0020.xml</infon><infon key="id">tbl0020</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table xmlns:xlink=&quot;http://www.w3.org/1999/xlink&quot; frame=&quot;hsides&quot; rules=&quot;groups&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;&lt;inline-graphic xlink:href=&quot;fx1_lrg.gif&quot;/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>12578</offset><text>Table 4	 	</text></passage><passage><infon key="file">tbl0020.xml</infon><infon key="id">tbl0020</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table xmlns:xlink=&quot;http://www.w3.org/1999/xlink&quot; frame=&quot;hsides&quot; rules=&quot;groups&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;&lt;inline-graphic xlink:href=&quot;fx1_lrg.gif&quot;/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>12589</offset><text>	 	</text></passage><passage><infon key="file">tbl0020.xml</infon><infon key="id">tbl0020</infon><infon key="section_type">TABLE</infon><infon key="type">table_footnote</infon><offset>12593</offset><text>aBased on the answers to the survey questions of the three risk categories enlisted in Table 3.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>12689</offset><text>Personal risk indexes are, in order of increasing severity: risk-free, low-risk, moderate-risk, high-risk, severe-risk. Based on their risk index, users were subdivided into risk-free cases, risk cases (low- to severe-risk), and respiratory-risk cases (Table 4 ). Since the risk index is a triage tool, respiratory-risk cases without evidence of COVID-19 are treated separately, atypical pneumonia being one of the possible diagnoses.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>13124</offset><text>Georeferenced database</text></passage><passage><infon key="file">gr1_lrg.jpg</infon><infon key="id">fig0005</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>13147</offset><text>CDS platform front-end dashboard. The web application allows epidemiologists and public health specialists to visualize real-time data through a dashboard. The geographic information system displays several data layers, including population density, poverty index, overcrowding, medical center locations, business locations, and contributing users’ locations. The dashboard also shows descriptive statistics of all the variables of the CDS survey. Color codes: green (risk-free), low-risk (yellow), medium-risk (orange), high-risk (red), very high risk (maroon), respiratory signs only (purple). The image on the top right shows the location of the SLPMA (population 1.4 million) within Mexico (population 135 million). (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article).</text></passage><passage><infon key="file">gr1_lrg.jpg</infon><infon key="id">fig0005</infon><infon key="section_type">FIG</infon><infon key="type">fig</infon><offset>14000</offset><text>Fig. 1</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>14007</offset><text>Data collected through CDS includes the georeferenced users’ contributions, and a web application allows data visualization through a dashboard (Fig. 1 ) as soon as the user completes the survey.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>14205</offset><text>During the survey collection period, health authorities issued a home confinement recommendation. Visual inspection of the GPS data shows that most users completed and sent their surveys from residential areas, probably from their place of residence. These areas also encompass social and recreational activities.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>14519</offset><text>Spatial data analysis</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>14541</offset><text>Coronavirus infection spreads in clusters, whose early identification is essential for slowing down SARS-CoV-2 transmission. The spatial analysis allowed us to determine whether the geographical features of the data collected with the CDS app suggest the presence of COVID-19 clusters across geographical space and whether they coincide with those of confirmed COVID-19 case clusters. Two complementary statistical tools enabled quantification of spatial features: computation of point process descriptive statistics, and spatial correlation modeling. We emphasize that the risk index calculation combines information about risk of infection and risk of disease severity into one category. Therefore, clustering information derived from the index is useful to understand risk of infection, but not about risk of disease severity. This is important to interpret the data presented in the results section.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_3</infon><offset>15445</offset><text>Point process descriptive statistics</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>15482</offset><text>We used kernel density estimation tools to estimate point process intensity functions and visually explore risk-free and risk cases. We used Ripley’s K-function and Monte Carlo simulations to describe how point patterns occur over a given area and to determine whether they are dispersed, clustered, or randomly distributed. Point process statistics computation is described in Appendix B.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_3</infon><offset>15874</offset><text>Spatial correlation modeling</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>15903</offset><text>Point process statistics allowed us to establish clustering features in CDS geographic data from observed point pattern correlations. An approach to account for these correlations is the log-Gaussian Cox process model, which describes the spatial distribution of symptoms as a function of explanatory variables and estimates a residual process independent of these variables (Appendix C).</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_1</infon><offset>16292</offset><text>Results</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>16300</offset><text>Socio-demographic users’ features (RQ1)</text></passage><passage><infon key="file">tbl0025.xml</infon><infon key="id">tbl0025</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>16342</offset><text>Age and gender distribution of CDS dataa.</text></passage><passage><infon key="file">tbl0025.xml</infon><infon key="id">tbl0025</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot;&gt;&lt;thead&gt;&lt;tr&gt;&lt;th align=&quot;left&quot;&gt;Age group (years)&lt;/th&gt;&lt;th colspan=&quot;2&quot; align=&quot;left&quot;&gt;Male (M)&lt;/th&gt;&lt;th colspan=&quot;2&quot; align=&quot;left&quot;&gt;Female (F)&lt;/th&gt;&lt;th colspan=&quot;2&quot; align=&quot;left&quot;&gt;All&lt;/th&gt;&lt;th align=&quot;left&quot;&gt;M/F ratio&lt;/th&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;10−19&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;33&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;2.1%&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;22&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1.4 %&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;55&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;3.5%&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1.50&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;20−29&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;346&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;22.3%&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;338&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;21.8%&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;684&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;44.0 %&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1.02&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;30−39&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;202&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;13.0%&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;217&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;14.0%&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;419&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;27.0%&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;0.93&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;40−49&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;115&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;7.4%&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;104&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;6.7 %&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;219&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;14.1%&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1.11&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;50−59&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;63&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;4.1%&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;61&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;3.9%&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;124&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;8.0%&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1.03&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;60−69&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;21&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1.4 %&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;25&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1.6%&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;46&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;3.0%&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;0.84&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;70−79&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;3&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;0.2%&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;4&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;0.3%&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;7&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;0.5%&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;0.75&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Total&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;783&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;50.4 %&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;771&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;49.6 %&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1554&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;100.0%&lt;/td&gt;&lt;td align=&quot;left&quot;/&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>16384</offset><text>Table 5	 	</text></passage><passage><infon key="file">tbl0025.xml</infon><infon key="id">tbl0025</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot;&gt;&lt;thead&gt;&lt;tr&gt;&lt;th align=&quot;left&quot;&gt;Age group (years)&lt;/th&gt;&lt;th colspan=&quot;2&quot; align=&quot;left&quot;&gt;Male (M)&lt;/th&gt;&lt;th colspan=&quot;2&quot; align=&quot;left&quot;&gt;Female (F)&lt;/th&gt;&lt;th colspan=&quot;2&quot; align=&quot;left&quot;&gt;All&lt;/th&gt;&lt;th align=&quot;left&quot;&gt;M/F ratio&lt;/th&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;10−19&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;33&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;2.1%&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;22&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1.4 %&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;55&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;3.5%&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1.50&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;20−29&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;346&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;22.3%&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;338&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;21.8%&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;684&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;44.0 %&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1.02&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;30−39&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;202&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;13.0%&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;217&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;14.0%&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;419&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;27.0%&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;0.93&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;40−49&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;115&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;7.4%&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;104&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;6.7 %&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;219&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;14.1%&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1.11&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;50−59&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;63&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;4.1%&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;61&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;3.9%&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;124&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;8.0%&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1.03&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;60−69&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;21&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1.4 %&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;25&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1.6%&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;46&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;3.0%&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;0.84&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;70−79&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;3&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;0.2%&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;4&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;0.3%&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;7&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;0.5%&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;0.75&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Total&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;783&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;50.4 %&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;771&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;49.6 %&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1554&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;100.0%&lt;/td&gt;&lt;td align=&quot;left&quot;/&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>16395</offset><text>Age group (years)	Male (M)	Female (F)	All	M/F ratio	 	10−19	33	2.1%	22	1.4 %	55	3.5%	1.50	 	20−29	346	22.3%	338	21.8%	684	44.0 %	1.02	 	30−39	202	13.0%	217	14.0%	419	27.0%	0.93	 	40−49	115	7.4%	104	6.7 %	219	14.1%	1.11	 	50−59	63	4.1%	61	3.9%	124	8.0%	1.03	 	60−69	21	1.4 %	25	1.6%	46	3.0%	0.84	 	70−79	3	0.2%	4	0.3%	7	0.5%	0.75	 	Total	783	50.4 %	771	49.6 %	1554	100.0%		 	</text></passage><passage><infon key="file">tbl0025.xml</infon><infon key="id">tbl0025</infon><infon key="section_type">TABLE</infon><infon key="type">table_footnote</infon><offset>16784</offset><text>In the SLPMA the predominant age groups are, in descending order, those of 10−19 years (18.65 %), 20–29 years (17.54 %), 0−9 years (16.65 %), and 40–49-years (13.29 %). Our study did not consider children under 10 years of age.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>17020</offset><text>Contributors to CDS surveys resided in Mexico (n = 2125) and other countries (United States, Bolivia, Chile, Spain, Argentina, France, and Bangladesh; n = 64). Only SLPMA users (n = 1554) were included in this study, whose overall mean age ± SD was 33.5 ± 11.5 years, with a median of 30.0 years (Table 5 ). The predominant age group was that of 20−29 years (44.0 %). The three largest groups, spanning 20–49 years, comprised 85.1 % of the total. Female and male contributors represented 49.6 % and 50.4 %, respectively.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>17547</offset><text>Spatial analysis of the risk cases</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_3</infon><offset>17582</offset><text>Geographic distribution of risk indexes (RQ2)</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>17628</offset><text>The SLPMA has 1,094,177 inhabitants distributed over 1,787.72 km2. This area is subdivided into AGEBs with a mean ± SD size of 3.80 ± 5.88 km2, and a mean ± SD population of 2348 ± 3098 inhabitants.</text></passage><passage><infon key="file">gr2_lrg.jpg</infon><infon key="id">fig0010</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>17831</offset><text>Population density per AGEB. Heat-map of the normalized population density per AGEB of the SLPMA. Black points represent risk cases. Density values are normalized by the total SLPMA area and its overall population size. Pearson’s correlation coefficient between population density and the number of risk cases per AGEB is 0.17.</text></passage><passage><infon key="file">gr2_lrg.jpg</infon><infon key="id">fig0010</infon><infon key="section_type">FIG</infon><infon key="type">fig</infon><offset>18161</offset><text>Fig. 2</text></passage><passage><infon key="file">gr3_lrg.jpg</infon><infon key="id">fig0015</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>18168</offset><text>Heat-map of risk cases per AGEB. Geographic distribution of the risk indexes of the users’ contributions. Each AGEB is color-coded according to the number of contributions recorded within it, divided by the total number of AGEB contributions. Color bars show the number of normalized counts as a percentage. The darker color in a given AGEB indicates higher count contributions. The color palette used for each map indicates a specific risk level: (a) low-risk, yellow; (b) medium-risk, orange; (c) high-risk, red; (d) very high-risk, brown; (e) respiratory symptoms, purple; (f) no-risk/no-symptoms, green. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article).</text></passage><passage><infon key="file">gr3_lrg.jpg</infon><infon key="id">fig0015</infon><infon key="section_type">FIG</infon><infon key="type">fig</infon><offset>18909</offset><text>Fig. 3</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>18916</offset><text>A population density map is shown in Fig. 2 , and the AGEBs heat-map of risk cases shown in Fig. 3 depicts the normalized number of risk reports per AGEB, conditioned to a given risk index, to provide information on the conditional probability of the number of reports. This figure intends to depict the normalized number of risk reports per AGEB, conditioned to a given risk category (low-risk, medium-risk, etc.); namely the heat maps provide information a conditional probability on the number of reports. The following data are presented as supplementary material: personal risk index distribution by gender and age in Table S 2, occupation distribution of risk cases by gender in Table S 3, personal risk index distribution by gender in Table S 4, and overall distribution of risk factors in Table S 5.</text></passage><passage><infon key="file">gr4_lrg.jpg</infon><infon key="id">fig0020</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>19724</offset><text>Intensity functions in the geographic space. Estimated sample intensity functions are shown as green-shaded areas in the maps for the point processes representing app users’ contributions: (a) all users’ contributions; (b) no-risk cases; (c) risk cases (those between low- and severe-risk). Black plus signs represent app users’ contributions. Darker green areas represent higher intensity. Locations with maximum empirical intensity values are indicated with a red plus sign. Kernel density estimation techniques (with kernel bandwidth h = 1200 m) enabled the calculation of intensity functions. The maximum intensity value for risk cases (Fig. 4c) is located across the street of the City’s ISSSTE Hospital General, a few meters away from one of the oldest tree-lined pedestrian streets (Calzada de Guadalupe). People use this avenue for recreational/religious purposes, such as visiting the Nuestra Señora de Guadalupe Sanctuary. Close to this location is a children’s park, the Center for the Arts, the Red Cross, and a military garrison. Mobility and social interactions in this area were significant during the study period despite the mitigation measures recommended by health authorities. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article).</text></passage><passage><infon key="file">gr4_lrg.jpg</infon><infon key="id">fig0020</infon><infon key="section_type">FIG</infon><infon key="type">fig</infon><offset>21063</offset><text>Fig. 4</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>21070</offset><text>Point process analysis of the risk cases generated darker green areas indicating higher intensity. Fig. 4 depicts the spatial distribution of all survey contributions, no-risk cases, and risk (low- to severe-risk) cases. This figure aims to provide an alternative visualization of raw data collected and how they segregate as a function of all users’ risk and no-risk contributions. These functions consider kernel density estimation techniques with a bandwidth h = 1200 m. Lower bandwidth values are more likely to overfit data. Note that Fig. 4c summarizes raw data from Fig. 3a–d.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>21658</offset><text>Most CDS contributions corresponded to non-risk cases (Fig. 4b); risk cases amounted to 15.77 %, and their maximum intensity was located in an area of high mobility and social interaction (Fig. 4c) which is also a populated residential area.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_3</infon><offset>21900</offset><text>Point pattern clustering features (RQ3)</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_4</infon><offset>21940</offset><text>Point process descriptive statistics</text></passage><passage><infon key="file">gr5_lrg.jpg</infon><infon key="id">fig0025</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>21977</offset><text>Spatial distribution patterns of risk cases. Period I: (a) L-function (solid line) and upper and lower envelopes (dashed lines) from Monte Carlo simulations for risk cases. The L function is above the upper envelope at scales between 0 and 600 m, suggesting significant clustering features (L &gt; Lup &gt; 0, p &lt; 0.001) at these scales. (b) The corresponding p-values for each h in the analysis range. The red dashed line represents a p-value of 0.0. Period II: (c) L-function (solid line) and upper and lower envelopes (dashed lines) resulting from MC simulations for the risk cases. (d) The L function is above the upper envelope at scales between 0 and 730 m, suggesting significant clustering features (L &gt; Lup &gt; 0, p &lt; 0.001) at these scales. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article).</text></passage><passage><infon key="file">gr5_lrg.jpg</infon><infon key="id">fig0025</infon><infon key="section_type">FIG</infon><infon key="type">fig</infon><offset>22851</offset><text>Fig. 5</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>22858</offset><text>Ripley’s L function was computed using Procedure I of Appendix B to test whether the point patterns of risk cases fulfill the nonhomogeneous CSR hypothesis. The reference probability measure was given by the AGEBs population (Fig. 2). L functions of Periods I (April-May) and II (April-July) are shown in Fig. 5 .</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>23174</offset><text>The L-function (solid line) and the corresponding upper and lower envelopes (dashed lines) for risk cases computed with Period I and Period II data are shown in Fig. 5a and c, respectively. The L function is above the upper envelope at scales between 0 and 600 m (0 and 730 m), suggesting that accumulated risk cases do not fulfill the CRS hypothesis and exhibit clustering features in this spatial range (L &gt; Lup &gt; 0, p &lt; 0.001). Fig. 5b and d show the corresponding p-values, where the red dashed line represents p = 0.01.</text></passage><passage><infon key="file">gr6_lrg.jpg</infon><infon key="id">fig0030</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>23699</offset><text>Risk-case clusters. Local tests of homogeneous CSR hypotheses. These tests were conducted to reveal point clusters at different spatial scales (h = 300, 450, and 600 m). Point clusters are defined as geographical areas where p-values &lt; 0.05. (a-c) Period I (April-May). (d-f) Period II (April-July).</text></passage><passage><infon key="file">gr6_lrg.jpg</infon><infon key="id">fig0030</infon><infon key="section_type">FIG</infon><infon key="type">fig</infon><offset>23999</offset><text>Fig. 6</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>24006</offset><text>Procedure 2 of Appendix B enabled local tests of homogeneous CSR hypotheses. Fig. 6 shows color-labeled AGEBs of the SLPMA with p-values &lt; 0.05 calculated at scales of 300, 450, and 600 m for Period I and Period II. Several AGEBs exhibited statistically significant clusters (Fig. 6 d–f) at different scales in the 0−730 m range. Risk-cases clusters from Period II are those statistically significant at a 730 m scale. Period I has similar results at different scales in the 0−600 m range (Fig. 6 a–c) with risk case clusters as those statistically significant at a 600 m scale. Some risk clusters computed in Period I intersect those computed in Period II (compare Fig. 6 a–c and d-f plots).</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_4</infon><offset>24709</offset><text>Spatial correlation model</text></passage><passage><infon key="file">gr7_lrg.jpg</infon><infon key="id">fig0035</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>24735</offset><text>Areas of a high incidence of risk symptoms for Period II data. The posterior exceedance probabilities P(exp(Y) &gt; k|X) computed for several values of k identified areas of the SLPMA with a particularly high incidence of risk symptoms. The figure shows the exceedence probability for k = 1.</text></passage><passage><infon key="file">gr7_lrg.jpg</infon><infon key="id">fig0035</infon><infon key="section_type">FIG</infon><infon key="type">fig</infon><offset>25024</offset><text>Fig. 7</text></passage><passage><infon key="file">tbl0030.xml</infon><infon key="id">tbl0030</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>25031</offset><text>Summary of the latent field parameters.</text></passage><passage><infon key="file">tbl0030.xml</infon><infon key="id">tbl0030</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot;&gt;&lt;thead&gt;&lt;tr&gt;&lt;th align=&quot;left&quot;&gt;Parameter&lt;/th&gt;&lt;th align=&quot;left&quot;&gt;Significant effect&lt;/th&gt;&lt;th align=&quot;left&quot;&gt;Relative risk&lt;/th&gt;&lt;th align=&quot;left&quot;&gt;Median (95 % Confidence Interval)&lt;/th&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;σ&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;--&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;--&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1.66 (1.39–1.90)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;φ&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;--&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;--&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;153.20 (99.51–240.60)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Population density&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Yes&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Increase&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;2.32 (1.90–2.90)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Travel abroad&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Yes&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Increase&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;9.50 (4.92–19.59)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Contact with suspect COVID-19 patient&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Yes&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Increase&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;7.84 (4.27–14.35)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Contact with confirmed COVID-19 patient&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Yes&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Increase&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;2.55 (1.38–4.84)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Risk conditions&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Yes&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Increase&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;2.05 (1.13–3.83)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Age&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;No&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Reduction&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;0.98 (0.97–2.46)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Male proportion&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;No&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Increase&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1.46 (0.83–2.46)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Comorbidities&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;No&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Increase&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1.23 (0.75–2.19)&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>25071</offset><text>Table 6	 	</text></passage><passage><infon key="file">tbl0030.xml</infon><infon key="id">tbl0030</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot;&gt;&lt;thead&gt;&lt;tr&gt;&lt;th align=&quot;left&quot;&gt;Parameter&lt;/th&gt;&lt;th align=&quot;left&quot;&gt;Significant effect&lt;/th&gt;&lt;th align=&quot;left&quot;&gt;Relative risk&lt;/th&gt;&lt;th align=&quot;left&quot;&gt;Median (95 % Confidence Interval)&lt;/th&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;σ&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;--&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;--&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1.66 (1.39–1.90)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;φ&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;--&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;--&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;153.20 (99.51–240.60)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Population density&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Yes&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Increase&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;2.32 (1.90–2.90)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Travel abroad&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Yes&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Increase&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;9.50 (4.92–19.59)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Contact with suspect COVID-19 patient&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Yes&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Increase&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;7.84 (4.27–14.35)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Contact with confirmed COVID-19 patient&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Yes&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Increase&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;2.55 (1.38–4.84)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Risk conditions&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Yes&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Increase&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;2.05 (1.13–3.83)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Age&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;No&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Reduction&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;0.98 (0.97–2.46)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Male proportion&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;No&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Increase&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1.46 (0.83–2.46)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Comorbidities&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;No&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Increase&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1.23 (0.75–2.19)&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>25082</offset><text>Parameter	Significant effect	Relative risk	Median (95 % Confidence Interval)	 	σ	--	--	1.66 (1.39–1.90)	 	φ	--	--	153.20 (99.51–240.60)	 	Population density	Yes	Increase	2.32 (1.90–2.90)	 	Travel abroad	Yes	Increase	9.50 (4.92–19.59)	 	Contact with suspect COVID-19 patient	Yes	Increase	7.84 (4.27–14.35)	 	Contact with confirmed COVID-19 patient	Yes	Increase	2.55 (1.38–4.84)	 	Risk conditions	Yes	Increase	2.05 (1.13–3.83)	 	Age	No	Reduction	0.98 (0.97–2.46)	 	Male proportion	No	Increase	1.46 (0.83–2.46)	 	Comorbidities	No	Increase	1.23 (0.75–2.19)	 	</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>25660</offset><text>We conducted Bayesian inference of a log-Gaussian Cox model of the risk cases data considering seven covariates: population density, male proportion, age, travel abroad or contact with someone who traveled abroad, contact with a suspect COVID-19 case, contact with a confirmed COVID-19 case, risk conditions, and comorbidities. Calculations were conducted over a 128 × 128 grid. The Markov chain Monte Carlo inference algorithm was run with 2,200,000 iterations, an initial burn-in of 200,000 iterations followed by 2,000,000 further iterations from which every 1000th sample was stored. Markov chain mixing and convergence were conducted through standard techniques. To reveal SLPMA areas with a high incidence of risk symptoms (Fig. 7 ) we also computed exceedance probabilities (Appendix C) with the variance σ2, scale φ, and other latent field parameters enlisted in Table 6 .</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_3</infon><offset>26547</offset><text>Distribution of risk-clusters and confirmed COVID-19-clusters (RQ4)</text></passage><passage><infon key="file">tbl0035.xml</infon><infon key="id">tbl0035</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>26615</offset><text>Top five SLPMA neighborhoods with clusters of confirmed COVID-19 cases during March 12 and August 3, 2020.</text></passage><passage><infon key="file">tbl0035.xml</infon><infon key="id">tbl0035</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot;&gt;&lt;thead&gt;&lt;tr&gt;&lt;th align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;3&quot;&gt;Month&lt;/th&gt;&lt;th align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;3&quot;&gt;Accumulated neighborhoods&lt;/th&gt;&lt;th align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;3&quot;&gt;Accumulated cases&lt;/th&gt;&lt;th colspan=&quot;3&quot; align=&quot;left&quot;&gt;The top five COVID-19 case clusters per neighborhood&lt;hr/&gt;&lt;/th&gt;&lt;/tr&gt;&lt;tr&gt;&lt;th align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;2&quot;&gt;Neighborhood&lt;/th&gt;&lt;th colspan=&quot;2&quot; align=&quot;left&quot;&gt;Cases&lt;hr/&gt;&lt;/th&gt;&lt;/tr&gt;&lt;tr&gt;&lt;th align=&quot;left&quot;&gt;Number&lt;/th&gt;&lt;th align=&quot;left&quot;&gt;%&lt;/th&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;5&quot;&gt;March (M1)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;5&quot;&gt;27&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;5&quot;&gt;42&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;La Forestal&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;5&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;11.9&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;La Loma&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;5&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;11.9&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Colonia 107&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;3&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;7.1&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Tangamanga&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;2&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;4.8&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;San Pedro&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;2&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;4.8&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;5&quot;&gt;April (M2)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;5&quot;&gt;85&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;5&quot;&gt;147&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Industrial Aviación&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;7&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;4.8&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Maya Mil&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;6&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;4.1&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;21 de Marzo&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;6&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;4.1&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;La Forestal&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;5&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;3.4&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;La Loma&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;5&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;3.4&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;5&quot;&gt;May (M3)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;5&quot;&gt;287&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;5&quot;&gt;616&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Tequisquiapan area&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;13&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;2.1&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Jardines del Sur&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;12&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;2.0&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;21 de Marzo&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;12&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;2.0&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;San Ángel&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;11&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1.8&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;San Ángel Inn&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;9&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1.5&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;5&quot;&gt;June (M4)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;5&quot;&gt;587&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;5&quot;&gt;1827&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Centro&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;29&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1.6&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Tequisquiapan area&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;26&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1.4&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;San Ángel&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;26&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1.4&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Jardines Sur&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;24&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1.3&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Las Mercedes&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;22&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1.2&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;5&quot;&gt;July (M5)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;5&quot;&gt;1076&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;5&quot;&gt;6180&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Centro&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;133&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;2.2&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Tequisquiapan area&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;106&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1.7&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Simón Díaz&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;72&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1.7&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Las Mercedes&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;69&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1.1&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Satélite&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;66&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1.1&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;5&quot;&gt;August (M6)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;5&quot;&gt;1315&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;5&quot;&gt;8592&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Centro&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;161&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1.9&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Tequisquiapan area&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;138&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1.6&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Progreso&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;107&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1.2&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Simón Díaz&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;97&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1.1&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Capricornio&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;97&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1.1&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>26722</offset><text>Table 7	 	</text></passage><passage><infon key="file">tbl0035.xml</infon><infon key="id">tbl0035</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot;&gt;&lt;thead&gt;&lt;tr&gt;&lt;th align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;3&quot;&gt;Month&lt;/th&gt;&lt;th align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;3&quot;&gt;Accumulated neighborhoods&lt;/th&gt;&lt;th align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;3&quot;&gt;Accumulated cases&lt;/th&gt;&lt;th colspan=&quot;3&quot; align=&quot;left&quot;&gt;The top five COVID-19 case clusters per neighborhood&lt;hr/&gt;&lt;/th&gt;&lt;/tr&gt;&lt;tr&gt;&lt;th align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;2&quot;&gt;Neighborhood&lt;/th&gt;&lt;th colspan=&quot;2&quot; align=&quot;left&quot;&gt;Cases&lt;hr/&gt;&lt;/th&gt;&lt;/tr&gt;&lt;tr&gt;&lt;th align=&quot;left&quot;&gt;Number&lt;/th&gt;&lt;th align=&quot;left&quot;&gt;%&lt;/th&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;5&quot;&gt;March (M1)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;5&quot;&gt;27&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;5&quot;&gt;42&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;La Forestal&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;5&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;11.9&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;La Loma&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;5&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;11.9&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Colonia 107&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;3&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;7.1&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Tangamanga&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;2&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;4.8&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;San Pedro&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;2&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;4.8&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;5&quot;&gt;April (M2)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;5&quot;&gt;85&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;5&quot;&gt;147&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Industrial Aviación&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;7&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;4.8&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Maya Mil&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;6&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;4.1&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;21 de Marzo&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;6&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;4.1&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;La Forestal&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;5&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;3.4&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;La Loma&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;5&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;3.4&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;5&quot;&gt;May (M3)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;5&quot;&gt;287&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;5&quot;&gt;616&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Tequisquiapan area&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;13&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;2.1&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Jardines del Sur&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;12&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;2.0&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;21 de Marzo&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;12&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;2.0&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;San Ángel&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;11&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1.8&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;San Ángel Inn&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;9&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1.5&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;5&quot;&gt;June (M4)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;5&quot;&gt;587&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;5&quot;&gt;1827&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Centro&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;29&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1.6&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Tequisquiapan area&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;26&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1.4&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;San Ángel&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;26&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1.4&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Jardines Sur&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;24&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1.3&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Las Mercedes&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;22&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1.2&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;5&quot;&gt;July (M5)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;5&quot;&gt;1076&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;5&quot;&gt;6180&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Centro&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;133&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;2.2&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Tequisquiapan area&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;106&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1.7&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Simón Díaz&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;72&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1.7&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Las Mercedes&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;69&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1.1&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Satélite&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;66&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1.1&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;5&quot;&gt;August (M6)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;5&quot;&gt;1315&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;5&quot;&gt;8592&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Centro&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;161&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1.9&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Tequisquiapan area&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;138&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1.6&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Progreso&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;107&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1.2&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Simón Díaz&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;97&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1.1&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Capricornio&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;97&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1.1&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>26733</offset><text>Month	Accumulated neighborhoods	Accumulated cases	The top five COVID-19 case clusters per neighborhood	 	Neighborhood	Cases	 	Number	%	 	March (M1)	27	42	La Forestal	5	11.9	 	La Loma	5	11.9	 	Colonia 107	3	7.1	 	Tangamanga	2	4.8	 	San Pedro	2	4.8	 	April (M2)	85	147	Industrial Aviación	7	4.8	 	Maya Mil	6	4.1	 	21 de Marzo	6	4.1	 	La Forestal	5	3.4	 	La Loma	5	3.4	 	May (M3)	287	616	Tequisquiapan area	13	2.1	 	Jardines del Sur	12	2.0	 	21 de Marzo	12	2.0	 	San Ángel	11	1.8	 	San Ángel Inn	9	1.5	 	June (M4)	587	1827	Centro	29	1.6	 	Tequisquiapan area	26	1.4	 	San Ángel	26	1.4	 	Jardines Sur	24	1.3	 	Las Mercedes	22	1.2	 	July (M5)	1076	6180	Centro	133	2.2	 	Tequisquiapan area	106	1.7	 	Simón Díaz	72	1.7	 	Las Mercedes	69	1.1	 	Satélite	66	1.1	 	August (M6)	1315	8592	Centro	161	1.9	 	Tequisquiapan area	138	1.6	 	Progreso	107	1.2	 	Simón Díaz	97	1.1	 	Capricornio	97	1.1	 	</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>27624</offset><text>We compared the distribution of clusters identified from the 9971 SLPMA COVID-19 cases confirmed between March 12 and August 3, with the distribution of risk case clusters identified from the April-July surveys (Period II). Only 9453 confirmed COVID-19 patients (94.8 %) with known postal addresses were included in the comparison. Individual records included demographics, date when symptoms started, and date when the diagnosis was confirmed. Several neighborhoods had clusters of COVID-19 cases confirmed during Periods I and II (Table 7 ). A summary of the findings retaled to RQ4 are listed in Table 10.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">title_1</infon><offset>28233</offset><text>Discussion</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>28244</offset><text>Early detection of COVID-19 hotspots has been achieved in Israel through one-minute population-wide surveys. In the United Kingdom, a mobile app for real-time tracking of self-reported symptoms predicted potential COVID-19. CDS is a multi-use platform allowing early detection of COVID-19 hotspots that may be of use to prevent spreading, especially at the beginning of the epidemic, when data of confirmed cases are scarce.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>28669</offset><text>The sociodemographic features of CDS users result in a sampling bias whose sources, listed in Table 9, restrict the assessment to the surveyed population.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>28824</offset><text>Most CDS contributions corresponded to non-risk cases (Fig. 4b); risk cases amounted to 15.77 % and their maximum intensity was located in an area of high mobility and social interaction (Fig. 4c). This urban space is also a populated residential area.</text></passage><passage><infon key="file">gr8_lrg.jpg</infon><infon key="id">fig0040</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>29077</offset><text>Socio-urban analysis of statistically significant point-pattern clusters. Risk-case clusters are shown by the shaded areas labeled A–E. Cluster A (294 confirmed COVID-19 cases), intersects several of the neighborhoods with the highest incidence of COVID-19 cases listed in Table 6, Table 7. Cluster B (138 confirmed COVID-19 cases) intersects the Tequisquiapan area that ranks second among the confirmed SARS-CoV-2 clusters. Cluster C (37 confirmed COVID-19 cases) intersects neighborhoods adjacent to the Tequisquiapan area. Cluster D (56 confirmed COVID-19 cases) includes the largest city park surrounded by a trail for strolling/jogging/biking. Cluster E (68 COVID-19 cases), on the northwest side of the park, intersect five neighborhoods. Cluster F (77 confirmed COVID-19 cases) intersects Graciano Sanchez municipality, which includes seven neighborhoods. H and J are groups of risk cases that also intersect areas with a high incidence of COVID-19 confirmed cases. (a) April-May data, (b) April-July data, (c) Exceedance probabilities P(exp(Y) &gt; k = 1 |X) associated with the covariate-adjusted latent field Y (April-July data).</text></passage><passage><infon key="file">gr8_lrg.jpg</infon><infon key="id">fig0040</infon><infon key="section_type">FIG</infon><infon key="type">fig</infon><offset>30216</offset><text>Fig. 8</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>30223</offset><text>Risk cases from Period II (April-July) had statistically significant spatial clustering independent of population density across geographical scales from 0 to 730 m (Fig. 6 d-f), and risk clusters were computed at a scale of 730 m. Independence of clustering from population density is further supported by the fact that the Pearson’s correlation coefficient between density and number of risk cases per AGEB is low () as show in Fig. 2. Similar results were obtained for clusters of COVID-19 cases confirmed in Period I (April-May) at a scale of 600 m (Fig. 6 a–c). Many Period II clusters have significant overlap, are more prominent, and expand several Period I clusters (Fig. 8 ).</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>30912</offset><text>Interestingly, Period II clusters also overlap city areas where the exceedance probabilities are close to one (Fig. 7). Risk case clusters in areas with a high incidence of risk of symptoms in Period I evolved to become the larger confirmed COVID-19 clusters of Period II (Fig. 7, Fig. 8).</text></passage><passage><infon key="file">gr9_lrg.jpg</infon><infon key="id">fig0045</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>31202</offset><text>Cumulative number of risk cases per week in risk cluster A from April to July (solid red line), and epidemiological curve of confirmed cases from March 12 to August 3 (solid black line). Both curves indicate risk cases with symptoms (April-May) preceded confirmed COVID-19 cases occurring during the exponential phase of the pandemic. Cluster A intersects 10 relevant neighborhoods: Bolivar, Torres del Santuario, Barrio de San Sebastián, Barrio de San Miguelito, Himno Nacional, Julián Carrillo, San Luis Rey, San Juan de Guadalupe, Independencia y Barrio de Guadalupe. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article).</text></passage><passage><infon key="file">gr9_lrg.jpg</infon><infon key="id">fig0045</infon><infon key="section_type">FIG</infon><infon key="type">fig</infon><offset>31906</offset><text>Fig. 9</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>31913</offset><text>Risk clusters computed with Period I and Period II data have significant spatial overlapping of neighborhoods with a high incidence of SARS-CoV-2 hotspots (Fig. 8, Fig. 9 ) and a substantial number of COVID-19 cases confirmed from March 12 to August 3.</text></passage><passage><infon key="file">tbl0040.xml</infon><infon key="id">tbl0040</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>32166</offset><text>Persistence and growth of clusters of confirmed COVID-19 cases in the SLPMA between March 12 and August 31, 2020.</text></passage><passage><infon key="file">tbl0040.xml</infon><infon key="id">tbl0040</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot;&gt;&lt;thead&gt;&lt;tr&gt;&lt;th align=&quot;left&quot;&gt;Neighborhoods with five top clusters&lt;/th&gt;&lt;th align=&quot;left&quot;&gt;Cases accumulated&lt;/th&gt;&lt;th align=&quot;left&quot;&gt;Cluster growth across time&lt;xref rid=&quot;tblfn0010&quot; ref-type=&quot;table-fn&quot;&gt;a&lt;/xref&gt;&lt;/th&gt;&lt;th align=&quot;left&quot;&gt;Persistence (months)&lt;/th&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Centro&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;161&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;82.0 % (M4-M6)&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;3&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Tequisquiapan area&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;138&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;81.1% (M3-M6)&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;4&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Progreso&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;107&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;0.0% (M6)&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Simón Díaz&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;97&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;25.8% (M5-M6)&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;2&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Capricornio&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;97&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;0.0% (M6)&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Las Mercedes&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;69&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;68.1% (M4-M5)&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;2&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Satélite&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;66&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;0.0% (M5)&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;San Ángel&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;26&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;57.7% (M3-M4)&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;2&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Jardines del Sur&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;24&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;50.0 % (M3-M4)&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;2&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;21 de Marzo&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;12&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;50.0 % (M2-M3)&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;2&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;San Angel Inn&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;9&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;0.0% (M3)&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Industrial Aviación&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;7&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;0.0% (M2)&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Maya Mil&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;6&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;0.0% (M2)&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Forestal&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;5&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;0.0% (M1-M2)&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;2&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;La Loma&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;5&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;0.0% (M1-M2)&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;2&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Tangamanga&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;2&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;0.0% (M1)&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;San Pedro&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;2&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;0.0% (M1)&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>32280</offset><text>Table 8	 	</text></passage><passage><infon key="file">tbl0040.xml</infon><infon key="id">tbl0040</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot;&gt;&lt;thead&gt;&lt;tr&gt;&lt;th align=&quot;left&quot;&gt;Neighborhoods with five top clusters&lt;/th&gt;&lt;th align=&quot;left&quot;&gt;Cases accumulated&lt;/th&gt;&lt;th align=&quot;left&quot;&gt;Cluster growth across time&lt;xref rid=&quot;tblfn0010&quot; ref-type=&quot;table-fn&quot;&gt;a&lt;/xref&gt;&lt;/th&gt;&lt;th align=&quot;left&quot;&gt;Persistence (months)&lt;/th&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Centro&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;161&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;82.0 % (M4-M6)&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;3&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Tequisquiapan area&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;138&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;81.1% (M3-M6)&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;4&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Progreso&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;107&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;0.0% (M6)&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Simón Díaz&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;97&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;25.8% (M5-M6)&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;2&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Capricornio&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;97&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;0.0% (M6)&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Las Mercedes&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;69&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;68.1% (M4-M5)&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;2&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Satélite&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;66&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;0.0% (M5)&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;San Ángel&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;26&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;57.7% (M3-M4)&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;2&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Jardines del Sur&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;24&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;50.0 % (M3-M4)&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;2&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;21 de Marzo&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;12&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;50.0 % (M2-M3)&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;2&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;San Angel Inn&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;9&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;0.0% (M3)&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Industrial Aviación&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;7&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;0.0% (M2)&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Maya Mil&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;6&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;0.0% (M2)&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Forestal&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;5&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;0.0% (M1-M2)&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;2&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;La Loma&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;5&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;0.0% (M1-M2)&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;2&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Tangamanga&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;2&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;0.0% (M1)&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;San Pedro&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;2&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;0.0% (M1)&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>32291</offset><text>Neighborhoods with five top clusters	Cases accumulated	Cluster growth across timea	Persistence (months)	 	Centro	161	82.0 % (M4-M6)	3	 	Tequisquiapan area	138	81.1% (M3-M6)	4	 	Progreso	107	0.0% (M6)	1	 	Simón Díaz	97	25.8% (M5-M6)	2	 	Capricornio	97	0.0% (M6)	1	 	Las Mercedes	69	68.1% (M4-M5)	2	 	Satélite	66	0.0% (M5)	1	 	San Ángel	26	57.7% (M3-M4)	2	 	Jardines del Sur	24	50.0 % (M3-M4)	2	 	21 de Marzo	12	50.0 % (M2-M3)	2	 	San Angel Inn	9	0.0% (M3)	1	 	Industrial Aviación	7	0.0% (M2)	1	 	Maya Mil	6	0.0% (M2)	1	 	Forestal	5	0.0% (M1-M2)	2	 	La Loma	5	0.0% (M1-M2)	2	 	Tangamanga	2	0.0% (M1)	1	 	San Pedro	2	0.0% (M1)	1	 	</text></passage><passage><infon key="file">tbl0040.xml</infon><infon key="id">tbl0040</infon><infon key="section_type">TABLE</infon><infon key="type">table_footnote</infon><offset>32925</offset><text>M1, month 1; M2, month 2; M3, month 3; M4, month 4; M5, month 5; M6, month 6.</text></passage><passage><infon key="file">tbl0045.xml</infon><infon key="id">tbl0045</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>33003</offset><text>Sources of data bias.</text></passage><passage><infon key="file">tbl0045.xml</infon><infon key="id">tbl0045</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot;&gt;&lt;thead&gt;&lt;tr&gt;&lt;th align=&quot;left&quot;&gt;Source&lt;/th&gt;&lt;th align=&quot;left&quot;&gt;Features&lt;/th&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;2&quot;&gt;Age of the sampled population&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;The highest proportion of &lt;italic&gt;CDS&lt;/italic&gt; users were those of 20−29 years (44.02%) and 30−39 years (26.96%). The predominant age groups were, in descending order, those of 10−19 years (18.65%), 20−29 years (17.54%), 0−9 years (16.65%), and 40–49-years (13.29%). Children under 10 years were not considered in this study.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;The predominant &lt;italic&gt;CDS&lt;/italic&gt; groups are adults with a smartphone and internet connection. The elderly population is less likely to have access to and master the mobile technology deployed in the field; the analysis was directed to risk cases younger than 65 years.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Availability of technological resources&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;The &lt;italic&gt;CDS&lt;/italic&gt; app was available for Android OS only; 68.3% of Mexico’s population has access to a smartphone, with 82.5% Android OS users, and 17.1% iOS users; the rest use Samsung, Windows, and PlayStation devices.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Availability of PCR COVID-19 tests&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Asymptomatic individuals infected with SARS-CoV-2 are not eligible for COVID-19 testing due to the limited number of tests available and therefore are not considered in the SSSLP data.&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>33025</offset><text>Table 9	 	</text></passage><passage><infon key="file">tbl0045.xml</infon><infon key="id">tbl0045</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot;&gt;&lt;thead&gt;&lt;tr&gt;&lt;th align=&quot;left&quot;&gt;Source&lt;/th&gt;&lt;th align=&quot;left&quot;&gt;Features&lt;/th&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; rowspan=&quot;2&quot;&gt;Age of the sampled population&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;The highest proportion of &lt;italic&gt;CDS&lt;/italic&gt; users were those of 20−29 years (44.02%) and 30−39 years (26.96%). The predominant age groups were, in descending order, those of 10−19 years (18.65%), 20−29 years (17.54%), 0−9 years (16.65%), and 40–49-years (13.29%). Children under 10 years were not considered in this study.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;The predominant &lt;italic&gt;CDS&lt;/italic&gt; groups are adults with a smartphone and internet connection. The elderly population is less likely to have access to and master the mobile technology deployed in the field; the analysis was directed to risk cases younger than 65 years.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Availability of technological resources&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;The &lt;italic&gt;CDS&lt;/italic&gt; app was available for Android OS only; 68.3% of Mexico’s population has access to a smartphone, with 82.5% Android OS users, and 17.1% iOS users; the rest use Samsung, Windows, and PlayStation devices.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Availability of PCR COVID-19 tests&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Asymptomatic individuals infected with SARS-CoV-2 are not eligible for COVID-19 testing due to the limited number of tests available and therefore are not considered in the SSSLP data.&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>33036</offset><text>Source	Features	 	Age of the sampled population	The highest proportion of CDS users were those of 20−29 years (44.02%) and 30−39 years (26.96%). The predominant age groups were, in descending order, those of 10−19 years (18.65%), 20−29 years (17.54%), 0−9 years (16.65%), and 40–49-years (13.29%). Children under 10 years were not considered in this study.	 	The predominant CDS groups are adults with a smartphone and internet connection. The elderly population is less likely to have access to and master the mobile technology deployed in the field; the analysis was directed to risk cases younger than 65 years.	 	Availability of technological resources	The CDS app was available for Android OS only; 68.3% of Mexico’s population has access to a smartphone, with 82.5% Android OS users, and 17.1% iOS users; the rest use Samsung, Windows, and PlayStation devices.	 	Availability of PCR COVID-19 tests	Asymptomatic individuals infected with SARS-CoV-2 are not eligible for COVID-19 testing due to the limited number of tests available and therefore are not considered in the SSSLP data.	 	</text></passage><passage><infon key="file">tbl0050.xml</infon><infon key="id">tbl0050</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>34142</offset><text>Key findings on RQ4.</text></passage><passage><infon key="file">tbl0050.xml</infon><infon key="id">tbl0050</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Most &lt;italic&gt;CDS&lt;/italic&gt; contributions corresponded to non-risk cases (&lt;xref rid=&quot;fig0020&quot; ref-type=&quot;fig&quot;&gt;Fig. 4&lt;/xref&gt;b); risk cases amounted to 15.77%, and their maximum intensity was located in a densely populated residential area of high mobility and social interaction (&lt;xref rid=&quot;fig0020&quot; ref-type=&quot;fig&quot;&gt;Fig. 4&lt;/xref&gt;c).&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Risk cases from Period II (April-July) had statistically significant spatial clustering independent of population density across geographical scales from 5 to 730 m (&lt;xref rid=&quot;fig0030&quot; ref-type=&quot;fig&quot;&gt;Fig. 6&lt;/xref&gt; d–f) and risk clusters were computed at a scale of 730 m. Similar results were obtained for clusters of COVID-19 cases confirmed in Period I (April-May) at a scale of 600 m (&lt;xref rid=&quot;fig0030&quot; ref-type=&quot;fig&quot;&gt;Fig. 6&lt;/xref&gt; a–c). Many Period II clusters have significant overlap, are more prominent and expand several Period I clusters (&lt;xref rid=&quot;fig0040&quot; ref-type=&quot;fig&quot;&gt;Fig. 8&lt;/xref&gt;).&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Period II clusters also overlap city areas where the exceedance probabilities are close to one (&lt;xref rid=&quot;fig0035&quot; ref-type=&quot;fig&quot;&gt;Fig. 7&lt;/xref&gt;). Risk case clusters in areas with a high incidence of risk of symptoms in Period I evolved to become the larger confirmed COVID-19 clusters of Period II (&lt;xref rid=&quot;fig0040&quot; ref-type=&quot;fig&quot;&gt;Fig. 8&lt;/xref&gt;).&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Risk case clusters A–E (&lt;xref rid=&quot;fig0040&quot; ref-type=&quot;fig&quot;&gt;Fig. 8&lt;/xref&gt;) were compared with the quantitative cluster analysis of COVID-19 confirmed cases. Cluster A (294 cases) had several cases comparable to the top-five confirmed neighborhoods. Cluster B (138 cases) and Cluster C (37 cases) intersect an area ranking second among confirmed SARS-CoV-2 hotspots. Cluster D (56 cases) includes the largest city park surrounded by a trail for strolling/jogging/biking. Cluster E (68 cases), on the northwest side of the park, intersects five neighborhoods. Cluster F (77 cases) intersects the Graciano Sanchez municipality, which includes seven neighborhoods.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Comparing the curve of cluster A showing the cumulative number of risk cases per week surveyed in Period II with that of confirmed cases in March 12 and August 3 (&lt;xref rid=&quot;fig0045&quot; ref-type=&quot;fig&quot;&gt;Fig. 9&lt;/xref&gt;) we observed that risk cases started in Period I, before the transition to the exponential phase of confirmed COVID-19 cases.&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>34163</offset><text>Table 10	 	</text></passage><passage><infon key="file">tbl0050.xml</infon><infon key="id">tbl0050</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Most &lt;italic&gt;CDS&lt;/italic&gt; contributions corresponded to non-risk cases (&lt;xref rid=&quot;fig0020&quot; ref-type=&quot;fig&quot;&gt;Fig. 4&lt;/xref&gt;b); risk cases amounted to 15.77%, and their maximum intensity was located in a densely populated residential area of high mobility and social interaction (&lt;xref rid=&quot;fig0020&quot; ref-type=&quot;fig&quot;&gt;Fig. 4&lt;/xref&gt;c).&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Risk cases from Period II (April-July) had statistically significant spatial clustering independent of population density across geographical scales from 5 to 730 m (&lt;xref rid=&quot;fig0030&quot; ref-type=&quot;fig&quot;&gt;Fig. 6&lt;/xref&gt; d–f) and risk clusters were computed at a scale of 730 m. Similar results were obtained for clusters of COVID-19 cases confirmed in Period I (April-May) at a scale of 600 m (&lt;xref rid=&quot;fig0030&quot; ref-type=&quot;fig&quot;&gt;Fig. 6&lt;/xref&gt; a–c). Many Period II clusters have significant overlap, are more prominent and expand several Period I clusters (&lt;xref rid=&quot;fig0040&quot; ref-type=&quot;fig&quot;&gt;Fig. 8&lt;/xref&gt;).&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Period II clusters also overlap city areas where the exceedance probabilities are close to one (&lt;xref rid=&quot;fig0035&quot; ref-type=&quot;fig&quot;&gt;Fig. 7&lt;/xref&gt;). Risk case clusters in areas with a high incidence of risk of symptoms in Period I evolved to become the larger confirmed COVID-19 clusters of Period II (&lt;xref rid=&quot;fig0040&quot; ref-type=&quot;fig&quot;&gt;Fig. 8&lt;/xref&gt;).&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Risk case clusters A–E (&lt;xref rid=&quot;fig0040&quot; ref-type=&quot;fig&quot;&gt;Fig. 8&lt;/xref&gt;) were compared with the quantitative cluster analysis of COVID-19 confirmed cases. Cluster A (294 cases) had several cases comparable to the top-five confirmed neighborhoods. Cluster B (138 cases) and Cluster C (37 cases) intersect an area ranking second among confirmed SARS-CoV-2 hotspots. Cluster D (56 cases) includes the largest city park surrounded by a trail for strolling/jogging/biking. Cluster E (68 cases), on the northwest side of the park, intersects five neighborhoods. Cluster F (77 cases) intersects the Graciano Sanchez municipality, which includes seven neighborhoods.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Comparing the curve of cluster A showing the cumulative number of risk cases per week surveyed in Period II with that of confirmed cases in March 12 and August 3 (&lt;xref rid=&quot;fig0045&quot; ref-type=&quot;fig&quot;&gt;Fig. 9&lt;/xref&gt;) we observed that risk cases started in Period I, before the transition to the exponential phase of confirmed COVID-19 cases.&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>34175</offset><text>Most CDS contributions corresponded to non-risk cases (Fig. 4b); risk cases amounted to 15.77%, and their maximum intensity was located in a densely populated residential area of high mobility and social interaction (Fig. 4c).	 	Risk cases from Period II (April-July) had statistically significant spatial clustering independent of population density across geographical scales from 5 to 730 m (Fig. 6 d–f) and risk clusters were computed at a scale of 730 m. Similar results were obtained for clusters of COVID-19 cases confirmed in Period I (April-May) at a scale of 600 m (Fig. 6 a–c). Many Period II clusters have significant overlap, are more prominent and expand several Period I clusters (Fig. 8).	 	Period II clusters also overlap city areas where the exceedance probabilities are close to one (Fig. 7). Risk case clusters in areas with a high incidence of risk of symptoms in Period I evolved to become the larger confirmed COVID-19 clusters of Period II (Fig. 8).	 	Risk case clusters A–E (Fig. 8) were compared with the quantitative cluster analysis of COVID-19 confirmed cases. Cluster A (294 cases) had several cases comparable to the top-five confirmed neighborhoods. Cluster B (138 cases) and Cluster C (37 cases) intersect an area ranking second among confirmed SARS-CoV-2 hotspots. Cluster D (56 cases) includes the largest city park surrounded by a trail for strolling/jogging/biking. Cluster E (68 cases), on the northwest side of the park, intersects five neighborhoods. Cluster F (77 cases) intersects the Graciano Sanchez municipality, which includes seven neighborhoods.	 	Comparing the curve of cluster A showing the cumulative number of risk cases per week surveyed in Period II with that of confirmed cases in March 12 and August 3 (Fig. 9) we observed that risk cases started in Period I, before the transition to the exponential phase of confirmed COVID-19 cases.	 	</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>36076</offset><text>The exponential growth of COVID-19 cases in the SLPMA began in June when public activities partially reopened, and SARS-CoV-2 hotspots increased significantly between May and August (Table 7, Table 8 ). The top infected neighborhood reached 161 confirmed COVID-19 cases with an 82 % increase between June and August (Table 8).</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>36403</offset><text>Analysis of the epidemiological curve and the trend line of risk-clusters by neighborhood shed light on the associations between risk clusters, symptoms, and actual infection hotspots (Fig. 9). Analysis of cluster A (Fig. 8b and c) showed that risk cases had symptoms between April and May (red line of Fig. 9) before confirmed COVID-19 cases started to appear during the transition to the exponential phase of the pandemic (black line of Fig. 9).</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>36851</offset><text>Despite the biases of this study (Table 9), our results support the hypothesis that the risk clusters identified early coincide with the infection hotspots confirmed later, and that early risk-clusters predict the areas of further SARS-CoV-2 spreading.</text></passage><passage><infon key="file">tbl0055.xml</infon><infon key="id">tbl0055</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>37104</offset><text>Future work key points.</text></passage><passage><infon key="file">tbl0055.xml</infon><infon key="id">tbl0055</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;An adequate response to the COVID-19 pandemic demands a fine-grained understanding of the population under study, since interventions have disparate effects on target populations, depending on multiple factors&lt;xref rid=&quot;bib0140&quot; ref-type=&quot;bibr&quot;&gt;28&lt;/xref&gt;. Since variation in the outcomes of pandemic interventions involves allocating extremely limited resources to different population sectors elicit different outcomes, the &lt;italic&gt;CDS&lt;/italic&gt; platform may be used as a valuable tool to optimize resource allocation.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Having a limited supply of COVID-19 tests is not a constraint unique to San Luis Potosí. Whatever few tests available used to diagnose those already with symptoms is not as informative when 40%–45% of those infected with SARS-CoV-2 will remain asymptomatic and the potential of the virus to spread silently may be significant&lt;xref rid=&quot;bib0145&quot; ref-type=&quot;bibr&quot;&gt;29&lt;/xref&gt;. Whereas extensive contact tracing via testing has been successful in South Korea and other countries, such a scale of testing is infeasible in Mexico. One possible solution involves using heterogeneous population factors to decide how to allocate tests differentially&lt;xref rid=&quot;bib0150&quot; ref-type=&quot;bibr&quot;&gt;30&lt;/xref&gt;. This approach may profit from using a tool as CDS to quantify risk and different citizen profiles in diverse geographies.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Information on the spatial distribution of cases during the spread of transmissible diseases is crucial to design and execute effective interventions. The CDS platform allows documentation and exploration of COVID-19 risk self-assessment data to enable epidemiological intelligence tasks, and may be extended to address epidemiological events concurrent with COVID-19, such as the next expected influenza A and B outbreaks. Survey data could also provide useful information to allocate vaccination campaigns across the state of San Luis Potosí and elsewhere.&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>37128</offset><text>Table 11	 	</text></passage><passage><infon key="file">tbl0055.xml</infon><infon key="id">tbl0055</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;An adequate response to the COVID-19 pandemic demands a fine-grained understanding of the population under study, since interventions have disparate effects on target populations, depending on multiple factors&lt;xref rid=&quot;bib0140&quot; ref-type=&quot;bibr&quot;&gt;28&lt;/xref&gt;. Since variation in the outcomes of pandemic interventions involves allocating extremely limited resources to different population sectors elicit different outcomes, the &lt;italic&gt;CDS&lt;/italic&gt; platform may be used as a valuable tool to optimize resource allocation.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Having a limited supply of COVID-19 tests is not a constraint unique to San Luis Potosí. Whatever few tests available used to diagnose those already with symptoms is not as informative when 40%–45% of those infected with SARS-CoV-2 will remain asymptomatic and the potential of the virus to spread silently may be significant&lt;xref rid=&quot;bib0145&quot; ref-type=&quot;bibr&quot;&gt;29&lt;/xref&gt;. Whereas extensive contact tracing via testing has been successful in South Korea and other countries, such a scale of testing is infeasible in Mexico. One possible solution involves using heterogeneous population factors to decide how to allocate tests differentially&lt;xref rid=&quot;bib0150&quot; ref-type=&quot;bibr&quot;&gt;30&lt;/xref&gt;. This approach may profit from using a tool as CDS to quantify risk and different citizen profiles in diverse geographies.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Information on the spatial distribution of cases during the spread of transmissible diseases is crucial to design and execute effective interventions. The CDS platform allows documentation and exploration of COVID-19 risk self-assessment data to enable epidemiological intelligence tasks, and may be extended to address epidemiological events concurrent with COVID-19, such as the next expected influenza A and B outbreaks. Survey data could also provide useful information to allocate vaccination campaigns across the state of San Luis Potosí and elsewhere.&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>37140</offset><text>An adequate response to the COVID-19 pandemic demands a fine-grained understanding of the population under study, since interventions have disparate effects on target populations, depending on multiple factors. Since variation in the outcomes of pandemic interventions involves allocating extremely limited resources to different population sectors elicit different outcomes, the CDS platform may be used as a valuable tool to optimize resource allocation.	 	Having a limited supply of COVID-19 tests is not a constraint unique to San Luis Potosí. Whatever few tests available used to diagnose those already with symptoms is not as informative when 40%–45% of those infected with SARS-CoV-2 will remain asymptomatic and the potential of the virus to spread silently may be significant. Whereas extensive contact tracing via testing has been successful in South Korea and other countries, such a scale of testing is infeasible in Mexico. One possible solution involves using heterogeneous population factors to decide how to allocate tests differentially. This approach may profit from using a tool as CDS to quantify risk and different citizen profiles in diverse geographies.	 	Information on the spatial distribution of cases during the spread of transmissible diseases is crucial to design and execute effective interventions. The CDS platform allows documentation and exploration of COVID-19 risk self-assessment data to enable epidemiological intelligence tasks, and may be extended to address epidemiological events concurrent with COVID-19, such as the next expected influenza A and B outbreaks. Survey data could also provide useful information to allocate vaccination campaigns across the state of San Luis Potosí and elsewhere.	 	</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>38885</offset><text>The key points for future work are listed in Table 11 .</text></passage><passage><infon key="section_type">AUTH_CONT</infon><infon key="type">title_1</infon><offset>38941</offset><text>Authors’ contributions</text></passage><passage><infon key="section_type">AUTH_CONT</infon><infon key="type">paragraph</infon><offset>38966</offset><text>Mobile phone data providing services such as contact tracing, mobility, and proximity assessment have proven to be of use for COVID-19 epidemiologic surveillance and support of appropriate public health interventions in several countries.</text></passage><passage><infon key="section_type">AUTH_CONT</infon><infon key="type">paragraph</infon><offset>39205</offset><text>We developed and successfully deployed CDS, a mobile crowdsourcing platform for COVID-19 surveillance that includes the CDS app, to survey self-reported signs, symptoms, and vulnerabilities in a city located in central Mexico.</text></passage><passage><infon key="section_type">AUTH_CONT</infon><infon key="type">paragraph</infon><offset>39432</offset><text>Real-time assessment of the users’ self-reported risk factors by the CDS platform provides early detection, prediction, and evolution of actual COVID-19 case clusters.</text></passage><passage><infon key="section_type">AUTH_CONT</infon><infon key="type">paragraph</infon><offset>39602</offset><text>Summary table </text></passage><passage><infon key="section_type">AUTH_CONT</infon><infon key="type">paragraph</infon><offset>39617</offset><text>Conception and design of the study: ACG, ARML, FDB, MLRM, MOR, RLR, SRC, VCRV. Data acquisition: CAA, FHM, MALS, MICI, EEHH. Analysis and interpretation of data: ACG, AEMN, FDB, MSGR, RLR, SRC, VCRV, VUMD. Drafting the manuscript: FMC, LAR, SRC, VCRV, RLR. All authors revised the manuscript and read and approved the version submitted. </text></passage><passage><infon key="section_type">COMP_INT</infon><infon key="type">title_1</infon><offset>39955</offset><text>Declaration of Competing Interest</text></passage><passage><infon key="section_type">COMP_INT</infon><infon key="type">paragraph</infon><offset>39989</offset><text>The authors report no declarations of interest.</text></passage><passage><infon key="section_type">REF</infon><infon key="type">title</infon><offset>40037</offset><text>References</text></passage><passage><infon key="fpage">278</infon><infon key="lpage">280</infon><infon key="name_0">surname:Velavan;given-names:T.P.</infon><infon key="name_1">surname:Meyer;given-names:C.G.</infon><infon key="pub-id_doi">10.1111/tmi.13383</infon><infon key="pub-id_pmid">32052514</infon><infon key="section_type">REF</infon><infon key="source">Trop. Med. Int. Health</infon><infon key="type">ref</infon><infon key="volume">25</infon><infon key="year">2020</infon><offset>40048</offset><text>The COVID-19 epidemic</text></passage><passage><infon key="fpage">463</infon><infon key="issue">8</infon><infon key="lpage">471</infon><infon key="name_0">surname:Suárez;given-names:V.</infon><infon key="name_1">surname:Suarez Quezada;given-names:M.</infon><infon key="name_2">surname:Oros Ruiz;given-names:S.</infon><infon key="name_3">surname:Ronquillo De Jesús;given-names:E.</infon><infon key="pub-id_doi">10.1016/j.rce.2020.05.007</infon><infon key="section_type">REF</infon><infon key="source">Rev. Clínica Española.</infon><infon key="type">ref</infon><infon key="volume">220</infon><infon key="year">2020</infon><offset>40070</offset><text>Epidemiología de COVID-19 en México: del 27 de febrero al 30 de abril de 2020</text></passage><passage><infon key="comment">(Accessed 24 June 2020)</infon><infon key="element-citation">https://coronavirus.gob.mx/2020/04/21/inicia-la-fase-3-por-covid-19-2/</infon><infon key="name_0">surname:Secretaria de Salud, Gobierno de México</infon><infon key="section_type">REF</infon><infon key="type">ref</infon><infon key="year">2020</infon><offset>40150</offset></passage><passage><infon key="comment">(Accessed 24 June 2020)</infon><infon key="element-citation">https://coronavirus.jhu.edu/data/mortality</infon><infon key="name_0">surname:Coronavirus Resource Center</infon><infon key="section_type">REF</infon><infon key="type">ref</infon><infon key="year">2020</infon><offset>40151</offset></passage><passage><infon key="element-citation">https://www.repository.cam.ac.uk/handle/1810/273772</infon><infon key="name_0">surname:Kissler;given-names:S.M.</infon><infon key="section_type">REF</infon><infon key="type">ref</infon><infon key="year">2017</infon><offset>40152</offset></passage><passage><infon key="fpage">1343</infon><infon key="lpage">1345</infon><infon key="name_0">surname:Cai;given-names:J.</infon><infon key="name_1">surname:Sun;given-names:W.</infon><infon key="name_2">surname:Huang;given-names:J.</infon><infon key="name_3">surname:Gamber;given-names:M.</infon><infon key="name_4">surname:Wu;given-names:J.</infon><infon key="name_5">surname:He;given-names:G.</infon><infon key="pub-id_doi">10.3201/eid2606.200412</infon><infon key="pub-id_pmid">32163030</infon><infon key="section_type">REF</infon><infon key="source">Emerg. Infect. Dis.</infon><infon key="type">ref</infon><infon key="volume">26</infon><infon key="year">2020</infon><offset>40153</offset><text>Indirect Virus Transmission in Cluster of COVID-19 Cases, Wenzhou, China, 2020</text></passage><passage><infon key="fpage">678</infon><infon key="lpage">688</infon><infon key="name_0">surname:Koo;given-names:J.R.</infon><infon key="name_1">surname:Cook;given-names:A.R.</infon><infon key="name_2">surname:Park;given-names:M.</infon><infon key="name_3">surname:Sun;given-names:Y.</infon><infon key="name_4">surname:Sun;given-names:H.</infon><infon key="name_5">surname:Lim;given-names:J.T.</infon><infon key="name_6">surname:Tam;given-names:C.</infon><infon key="name_7">surname:Dickens;given-names:B.L.</infon><infon key="pub-id_doi">10.1016/S1473-3099(20)30162-6</infon><infon key="pub-id_pmid">32213332</infon><infon key="section_type">REF</infon><infon key="source">Lancet Infect. Dis.</infon><infon key="type">ref</infon><infon key="volume">20</infon><infon key="year">2020</infon><offset>40232</offset><text>Interventions to mitigate early spread of SARS-CoV-2 in Singapore: a modelling study</text></passage><passage><infon key="name_0">surname:Hodcroft;given-names:E.B.</infon><infon key="pub-id_doi">10.4414/smw.2020.20212</infon><infon key="section_type">REF</infon><infon key="source">Swiss Med.</infon><infon key="type">ref</infon><infon key="volume">150</infon><infon key="year">2020</infon><offset>40317</offset><text>Preliminary case report on the SARS-CoV-2 cluster in the UK, France, and Spain</text></passage><passage><infon key="fpage">1</infon><infon key="lpage">4</infon><infon key="name_0">surname:Rossman;given-names:H.</infon><infon key="name_1">surname:Keshet;given-names:A.</infon><infon key="name_10">surname:Segal;given-names:E.</infon><infon key="name_2">surname:Shilo;given-names:S.</infon><infon key="name_3">surname:Gavrieli;given-names:A.</infon><infon key="name_4">surname:Bauman;given-names:T.</infon><infon key="name_5">surname:Cohen;given-names:O.</infon><infon key="name_6">surname:Shelly;given-names:E.</infon><infon key="name_7">surname:Balicer;given-names:R.</infon><infon key="name_8">surname:Geiger;given-names:B.</infon><infon key="name_9">surname:Dor;given-names:Y.</infon><infon key="pub-id_doi">10.1038/s41591-020-0857-9</infon><infon key="pub-id_pmid">31932805</infon><infon key="section_type">REF</infon><infon key="source">Nat. Med.</infon><infon key="type">ref</infon><infon key="year">2020</infon><offset>40396</offset><text>A framework for identifying regional outbreak and spread of COVID-19 from one-minute population-wide surveys</text></passage><passage><infon key="fpage">402</infon><infon key="name_0">surname:Peng;given-names:Z.</infon><infon key="name_1">surname:Wang;given-names:R.</infon><infon key="name_2">surname:Liu;given-names:L.</infon><infon key="name_3">surname:Wu;given-names:H.</infon><infon key="pub-id_doi">10.3390/ijgi9060402</infon><infon key="section_type">REF</infon><infon key="source">ISPRS Int. J. Geo-Inf.</infon><infon key="type">ref</infon><infon key="volume">9</infon><infon key="year">2020</infon><offset>40505</offset><text>Exploring urban spatial features of COVID-19 transmission in Wuhan based on social media data</text></passage><passage><infon key="element-citation">https://coronavirus.gob.mx/wp-content/uploads/2020/11/Prueba_antigenica_COVID_11Nov2020.pdf</infon><infon key="name_0">surname:Secretaría de Salud</infon><infon key="section_type">REF</infon><infon key="type">ref</infon><infon key="year">2020</infon><offset>40599</offset></passage><passage><infon key="element-citation">https://eena.org/document/covid-19-apps</infon><infon key="name_0">surname:Azevedo Silva;given-names:M.</infon><infon key="section_type">REF</infon><infon key="type">ref</infon><infon key="year">2020</infon><offset>40600</offset></passage><passage><infon key="element-citation">https://www.un.org/humansecurity/wp-content/uploads/2017/10/h2.pdf</infon><infon key="name_0">surname:Human Security Unit of the United Nations</infon><infon key="section_type">REF</infon><infon key="type">ref</infon><infon key="year">2016</infon><offset>40601</offset></passage><passage><infon key="fpage">304</infon><infon key="lpage">324</infon><infon key="name_0">surname:Phuttharak;given-names:J.</infon><infon key="name_1">surname:Loke;given-names:S.W.</infon><infon key="pub-id_doi">10.1109/ACCESS.2018.2885353</infon><infon key="section_type">REF</infon><infon key="source">IEEE Access</infon><infon key="type">ref</infon><infon key="volume">7</infon><infon key="year">2019</infon><offset>40602</offset><text>A review of mobile crowdsourcing architectures and challenges: toward crowd-empowered internet-of-things</text></passage><passage><infon key="element-citation">https://www.inegi.org.mx/app/ageeml/#</infon><infon key="name_0">surname:INEGI</infon><infon key="section_type">REF</infon><infon key="type">ref</infon><infon key="year">2020</infon><offset>40707</offset></passage><passage><infon key="element-citation">https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/</infon><infon key="name_0">surname:WHO</infon><infon key="section_type">REF</infon><infon key="type">ref</infon><infon key="year">2020</infon><offset>40708</offset></passage><passage><infon key="comment">(Accessed 13 October 2020)</infon><infon key="element-citation">https://www.who.int/news/item/03-04-2020-digital-technology-for-covid-19-response</infon><infon key="fpage">1</infon><infon key="name_0">surname:World Health Organization</infon><infon key="section_type">REF</infon><infon key="source">Newsletter</infon><infon key="type">ref</infon><infon key="year">2020</infon><offset>40709</offset><text>Digital technology for COVID-19 response</text></passage><passage><infon key="comment">(Accessed 13 October 2020)</infon><infon key="element-citation">https://covid19.sinave.gob.mx/</infon><infon key="name_0">surname:Sistema Nacional de Vigilancia Epidemiológica</infon><infon key="section_type">REF</infon><infon key="type">ref</infon><infon key="year">2020</infon><offset>40750</offset></passage><passage><infon key="fpage">47</infon><infon key="lpage">56</infon><infon key="name_0">surname:Zhou;given-names:Y.</infon><infon key="name_1">surname:Yang;given-names:Q.</infon><infon key="name_2">surname:Chi;given-names:J.</infon><infon key="name_3">surname:Dong;given-names:B.</infon><infon key="name_4">surname:Lv;given-names:W.</infon><infon key="name_5">surname:Shen;given-names:L.</infon><infon key="name_6">surname:Wang;given-names:Y.</infon><infon key="pub-id_doi">10.1016/j.ijid.2020.07.029</infon><infon key="pub-id_pmid">32721533</infon><infon key="section_type">REF</infon><infon key="source">Int. J. Infect. Dis.</infon><infon key="type">ref</infon><infon key="volume">99</infon><infon key="year">2020</infon><offset>40751</offset><text>Comorbidities and the risk of severe or fatal outcomes associated with coronavirus disease 2019: a systematic review and meta-analysis</text></passage><passage><infon key="element-citation">http://www.ilo.org/wcmsp5/groups/public/---americas/---ro-lima/documents/publication/wcms_245889.pdf</infon><infon key="name_0">surname:International Labor Organization</infon><infon key="section_type">REF</infon><infon key="type">ref</infon><infon key="year">2014</infon><offset>40886</offset></passage><passage><infon key="element-citation">https://coronavirus.gob.mx/wp-content/uploads/2020/10/Algoritmo_Dx_COVID_Flu_05Oct2020.pdf</infon><infon key="name_0">surname:Secretaría de Salud</infon><infon key="section_type">REF</infon><infon key="type">ref</infon><infon key="year">2020</infon><offset>40887</offset></passage><passage><infon key="name_0">surname:Kissler;given-names:S.M.</infon><infon key="pub-id_doi">10.17863/CAM.20834</infon><infon key="section_type">REF</infon><infon key="type">ref</infon><infon key="year">2017</infon><offset>40888</offset></passage><passage><infon key="fpage">322</infon><infon key="lpage">334</infon><infon key="name_0">surname:Cucala;given-names:L.</infon><infon key="pub-id_doi">10.1111/j.1467-9469.2007.00583.x</infon><infon key="section_type">REF</infon><infon key="source">Scand. Stat. Theory Appl.</infon><infon key="type">ref</infon><infon key="volume">35</infon><infon key="year">2008</infon><offset>40889</offset><text>Intensity estimation for spatial point processes observed with noise</text></passage><passage><infon key="fpage">1</infon><infon key="lpage">48</infon><infon key="name_0">surname:Taylor;given-names:B.M.</infon><infon key="name_1">surname:Davies;given-names:T.M.</infon><infon key="name_2">surname:Rowlingson;given-names:B.S.</infon><infon key="name_3">surname:Diggle;given-names:P.J.</infon><infon key="pub-id_doi">10.18637/jss.v063.i07</infon><infon key="section_type">REF</infon><infon key="source">J. Stat. Softw.</infon><infon key="type">ref</infon><infon key="volume">63</infon><infon key="year">2015</infon><offset>40958</offset><text>Bayesian inference and data augmentation schemes for spatial, spatiotemporal and multivariate log-gaussian cox processes in R</text></passage><passage><infon key="element-citation">https://www.wiley.com/en-mx/Applied+Spatial+Statistics+for+Public+Health+Data-p-9780471387718</infon><infon key="name_0">surname:Waller;given-names:L.A.</infon><infon key="name_1">surname:Gotway;given-names:C.A.</infon><infon key="section_type">REF</infon><infon key="type">ref</infon><infon key="year">2004</infon><offset>41084</offset></passage><passage><infon key="fpage">1037</infon><infon key="lpage">1040</infon><infon key="name_0">surname:Menni;given-names:C.</infon><infon key="name_1">surname:Valdes;given-names:A.M.</infon><infon key="name_10">surname:Visconti;given-names:A.</infon><infon key="name_11">surname:Hysi;given-names:P.</infon><infon key="name_12">surname:Bowyer;given-names:R.C.E.</infon><infon key="name_13">surname:Mangino;given-names:M.</infon><infon key="name_14">surname:Falchi;given-names:M.</infon><infon key="name_15">surname:Wolf;given-names:J.</infon><infon key="name_16">surname:Ourselin;given-names:S.</infon><infon key="name_17">surname:Chan;given-names:A.T.</infon><infon key="name_18">surname:Steves;given-names:C.J.</infon><infon key="name_19">surname:Spector;given-names:T.D.</infon><infon key="name_2">surname:Freidin;given-names:M.B.</infon><infon key="name_3">surname:Sudre;given-names:C.H.</infon><infon key="name_4">surname:Nguyen;given-names:L.H.</infon><infon key="name_5">surname:Drew;given-names:D.A.</infon><infon key="name_6">surname:Ganesh;given-names:S.</infon><infon key="name_7">surname:Varsavsky;given-names:T.</infon><infon key="name_8">surname:Cardoso;given-names:M.J.</infon><infon key="name_9">surname:El-Sayed Moustafa;given-names:J.S.</infon><infon key="pub-id_doi">10.1038/s41591-020-0916-2</infon><infon key="pub-id_pmid">32393804</infon><infon key="section_type">REF</infon><infon key="source">Nat. Med.</infon><infon key="type">ref</infon><infon key="volume">26</infon><infon key="year">2020</infon><offset>41085</offset><text>Real-time tracking of self-reported symptoms to predict potential COVID-19</text></passage><passage><infon key="fpage">1</infon><infon key="lpage">9</infon><infon key="name_0">surname:Wang;given-names:C.</infon><infon key="name_1">surname:Han;given-names:L.</infon><infon key="name_10">surname:Chou;given-names:R.</infon><infon key="name_11">surname:Lee;given-names:A.</infon><infon key="name_12">surname:Chen;given-names:A.</infon><infon key="name_13">surname:Bayus;given-names:B.</infon><infon key="name_14">surname:Tucker;given-names:J.D.</infon><infon key="name_2">surname:Stein;given-names:G.</infon><infon key="name_3">surname:Day;given-names:S.</infon><infon key="name_4">surname:Bien-Gund;given-names:C.</infon><infon key="name_5">surname:Mathews;given-names:A.</infon><infon key="name_6">surname:Ong;given-names:J.J.</infon><infon key="name_7">surname:Zhao;given-names:P.Z.</infon><infon key="name_8">surname:Wei;given-names:S.F.</infon><infon key="name_9">surname:Walker;given-names:J.</infon><infon key="pub-id_doi">10.1186/s40249-020-0622-9</infon><infon key="pub-id_pmid">31996251</infon><infon key="section_type">REF</infon><infon key="source">Infect. Dis. Poverty</infon><infon key="type">ref</infon><infon key="volume">9</infon><infon key="year">2020</infon><offset>41160</offset><text>Crowdsourcing in health and medical research: a systematic review</text></passage><passage><infon key="comment">(June 15, 2020). University of Chicago, Becker Friedman Institute for Economics Working Paper No. 2020-75</infon><infon key="name_0">surname:Akbarpour;given-names:M.</infon><infon key="name_1">surname:Cook;given-names:C.</infon><infon key="name_2">surname:Marzuoli;given-names:A.</infon><infon key="name_3">surname:Mongey;given-names:S.</infon><infon key="name_4">surname:Nagaraj;given-names:A.</infon><infon key="name_5">surname:Saccarola;given-names:M.</infon><infon key="name_6">surname:Tebaldi;given-names:P.</infon><infon key="name_7">surname:Vasserman;given-names:S.</infon><infon key="name_8">surname:Yang;given-names:H.</infon><infon key="pub-id_doi">10.2139/ssrn.3623593</infon><infon key="section_type">REF</infon><infon key="source">SSRN Electron. J.</infon><infon key="type">ref</infon><infon key="year">2020</infon><offset>41226</offset><text>Socioeconomic network heterogeneity and pandemic policy response</text></passage><passage><infon key="fpage">362</infon><infon key="lpage">367</infon><infon key="name_0">surname:Oran;given-names:D.P.</infon><infon key="name_1">surname:Topol;given-names:E.J.</infon><infon key="pub-id_doi">10.7326/M20-3012</infon><infon key="pub-id_pmid">32491919</infon><infon key="section_type">REF</infon><infon key="source">Ann. Intern. Med.</infon><infon key="type">ref</infon><infon key="volume">173</infon><infon key="year">2020</infon><offset>41291</offset><text>Prevalence of asymptomatic SARS-CoV-2 infection: a narrative review</text></passage><passage><infon key="element-citation">http://arxiv.org/abs/2004.01740</infon><infon key="name_0">surname:Biswas;given-names:A.</infon><infon key="name_1">surname:Bannur;given-names:S.</infon><infon key="name_2">surname:Jain;given-names:P.</infon><infon key="name_3">surname:Merugu;given-names:S.</infon><infon key="section_type">REF</infon><infon key="type">ref</infon><infon key="year">2020</infon><offset>41359</offset></passage><passage><infon key="comment">(Accessed 29 June 2020)</infon><infon key="element-citation">https://arxiv.org/abs/2006.07784</infon><infon key="name_0">surname:Pulido;given-names:D.</infon><infon key="name_1">surname:Basurto;given-names:D.</infon><infon key="name_2">surname:Cándido;given-names:M.</infon><infon key="name_3">surname:Salas;given-names:J.</infon><infon key="section_type">REF</infon><infon key="type">ref</infon><infon key="year">2020</infon><offset>41360</offset></passage><passage><infon key="fpage">375</infon><infon key="lpage">379</infon><infon key="name_0">surname:Hernández-Garduño;given-names:E.</infon><infon key="pub-id_doi">10.1016/j.orcp.2020.06.001</infon><infon key="pub-id_pmid">32536475</infon><infon key="section_type">REF</infon><infon key="source">Obes. Res. Clin. Pract.</infon><infon key="type">ref</infon><infon key="volume">14</infon><infon key="year">2020</infon><offset>41361</offset><text>Obesity is the comorbidity more strongly associated for Covid-19 in Mexico. A case-control study</text></passage></document></collection>
